Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English
Coverage 104,003 Raw stories ingested 10,045 rewritten in CS_CZ • 1 to rewrite (last 2 days).
Agents 7 Live Pipeline agents
  • FMP Stock News Fetch every minute 13s ago
  • FMP Forex News Fetch every 5 min 3m ago
  • CoinGecko News Fetch every 5 min 3m ago
  • FIO Stock News Fetch every 10 min 2m ago
  • Patria Stock News Fetch every 10 min 2m ago
  • Editorial rewrite Rewrite every minute running now
  • Asset sync Assets every 1 hour 32m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-06-12 19:40 1mo ago
2026-03-26 10:00 4mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. ("Yiren" or the "Company") (NYSE: YRD).
2026-06-12 19:40 1mo ago
2026-03-28 15:47 4mo ago
YRD Investors Have Opportunity to Join Yiren Digital Ltd. Fraud Investigation with the Schall Law Firm
YRD Yiren Digital
FMP Stock News
Original source text
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Yiren Digital Ltd. (“Yiren” or “the Company”) (NYSE: YRD) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Yiren announced its Q4 and full year 2025 financial results on March 19, 2026. The Company’s revenue was significantly below its guidance, and it suffered a net loss after reporting a profit in the prior-year period. The Company reported worsening delinquency rates for multiple categories. Based on this news, the Company’s ADRs fell by more than 44.8% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
2026-06-12 19:40 1mo ago
2026-03-31 17:54 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. (“Yiren” or the “Company”) (NYSE: YRD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
2026-06-12 19:40 1mo ago
2026-04-02 10:00 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. ("Yiren" or the "Company") (NYSE: YRD).
2026-06-12 19:40 1mo ago
2026-04-07 01:01 3mo ago
QuoteMedia (OTCMKTS:QMCI) versus Yirendai (NYSE:YRD) Financial Survey
YRD Yiren Digital
FMP Stock News
Original source text
Yirendai (NYSE: YRD - Get Free Report) and QuoteMedia (OTCMKTS:QMCI - Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and valuation. Profitability This table compares Yirendai and QuoteMedia's
2026-06-12 19:40 1mo ago
2026-04-07 16:57 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. (“Yiren” or the “Company”) (NYSE: YRD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   

The investigation concerns whether Yiren and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 19, 2026, Yiren announced its financial results for the fourth quarter and full year ended December 31, 2025.  Among other items, the Company reported fourth quarter revenue of approximately RMB 957.6 million, representing a decline of approximately 34% year-over-year and significantly below previously issued guidance of RMB 1.4 billion to RMB 1.6 billion.  Yiren also reported a net loss of approximately RMB 882.2 million for the quarter, compared to net income of approximately RMB 331.4 million in the prior-year period.  Yiren further disclosed that its provision for contingent liabilities increased significantly to approximately RMB 1.11 billion, up from approximately RMB 459.8 million in the prior quarter.  The Company also reported worsening delinquency rates across multiple categories, including increases in 1–30 day, 31–60 day, and 61–90 day delinquency rates compared to the prior quarter.  Yiren attributed these results to several factors, including a decline in service fee rates under a new regulatory framework, a strategic reduction in loan facilitation volume, and a higher-risk asset profile. 

On this news, Yiren’s American Depositary Receipt (“ADR”) price fell $1.65 per ADR, or 44.84%, to close at $2.03 per ADR on March 19, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.    

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
2026-06-12 19:40 1mo ago
2026-04-09 10:00 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. ("Yiren" or the "Company") (NYSE: YRD).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  

The investigation concerns whether Yiren and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 19, 2026, Yiren announced its financial results for the fourth quarter and full year ended December 31, 2025.  Among other items, the Company reported fourth quarter revenue of approximately RMB 957.6 million, representing a decline of approximately 34% year-over-year and significantly below previously issued guidance of RMB 1.4 billion to RMB 1.6 billion.  Yiren also reported a net loss of approximately RMB 882.2 million for the quarter, compared to net income of approximately RMB 331.4 million in the prior-year period.  Yiren further disclosed that its provision for contingent liabilities increased significantly to approximately RMB 1.11 billion, up from approximately RMB 459.8 million in the prior quarter.  The Company also reported worsening delinquency rates across multiple categories, including increases in 1–30 day, 31–60 day, and 61–90 day delinquency rates compared to the prior quarter.  Yiren attributed these results to several factors, including a decline in service fee rates under a new regulatory framework, a strategic reduction in loan facilitation volume, and a higher-risk asset profile. 

On this news, Yiren's American Depositary Receipt ("ADR") price fell $1.65 per ADR, or 44.84%, to close at $2.03 per ADR on March 19, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:

Danielle Peyton

Pomerantz LLP

[email protected]

646-581-9980 ext. 7980

SOURCE Pomerantz LLP
2026-06-12 19:40 1mo ago
2026-04-14 17:07 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. (“Yiren” or the “Company”) (NYSE: YRD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   

The investigation concerns whether Yiren and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 19, 2026, Yiren announced its financial results for the fourth quarter and full year ended December 31, 2025. Among other items, the Company reported fourth quarter revenue of approximately RMB 957.6 million, representing a decline of approximately 34% year-over-year and significantly below previously issued guidance of RMB 1.4 billion to RMB 1.6 billion. Yiren also reported a net loss of approximately RMB 882.2 million for the quarter, compared to net income of approximately RMB 331.4 million in the prior-year period. Yiren further disclosed that its provision for contingent liabilities increased significantly to approximately RMB 1.11 billion, up from approximately RMB 459.8 million in the prior quarter. The Company also reported worsening delinquency rates across multiple categories, including increases in 1–30 day, 31–60 day, and 61–90 day delinquency rates compared to the prior quarter. Yiren attributed these results to several factors, including a decline in service fee rates under a new regulatory framework, a strategic reduction in loan facilitation volume, and a higher-risk asset profile. 

On this news, Yiren’s American Depositary Receipt (“ADR”) price fell $1.65 per ADR, or 44.84%, to close at $2.03 per ADR on March 19, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.    

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
2026-06-12 19:40 1mo ago
2026-04-16 09:00 3mo ago
Yiren Digital Named to S&P Global Sustainability Yearbook (China Edition) 2026, Honored as Industry Mover
YRD Yiren Digital
FMP Stock News
Original source text
, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced its inclusion in the S&P Global Sustainability Yearbook (China Edition) 2026. Alongside this milestone, Yiren Digital was also honored with the "Industry Mover" distinction. The Yearbook is widely regarded as one of the most comprehensive annual publications evaluating corporate sustainability performance in China.

The recognition reflects Yiren Digital's performance in the 2025 S&P Global Corporate Sustainability Assessment (CSA), where the Company scored 50 out of 100, placing Yiren Digital in the top decile of the "Diversified Financial Services and Capital Markets" industry globally as of October 24, 2025, reflecting a 12-point improvement over the prior year. For the 2026 China Edition, nearly 1,800 companies were assessed, with only approximately 190 selected for inclusion. Yiren Digital was further honored with the "Industry Mover" distinction, recognizing the Company as the strongest year-over-year ESG performer in its industry. The Company delivered meaningful gains across key ESG dimensions, including a 6-point increase in governance and a 10-point increase in social performance. S&P Global classified the Company's overall data availability as High relative to industry peers.

"Our inclusion in the S&P Global Sustainability Yearbook (China Edition) 2026 reflects a conviction at the heart of our business: that a strong ESG strategy is inseparable from a strong fintech strategy," said Mr. Ning Tang, Chairman and Chief Executive Officer of Yiren Digital. "AI-powered risk management and information security are not simply compliance boxes to check; they are how we earn and keep the trust of the customers we serve. Expanding financial inclusion for underserved borrowers and small business owners is central to our mission. This recognition underscores that sustainable value creation and commercial growth are mutually reinforcing, and we will continue to build on that foundation."

Yiren Digital's Key Achievements in the 2025 Corporate Sustainability Assessment

Yiren Digital delivered strong performance across both the Social and Governance & Economic dimensions. The Social Dimension was Yiren Digital's strongest-performing dimension, with the Company achieving a score of 55/100, significantly ahead of the industry average of 24/100. The Governance & Economic Dimension also improved year over year, with performance exceeding industry averages across Risk & Crisis Management, Business Ethics and Information Security.

These results reflect the Company's continued focus on embedding risk management, data security and financial inclusion into its core operating model.

Yiren Digital's ESG Framework

Yiren Digital has established a three-tier ESG governance framework comprising a Board-level ESG Committee, management-level oversight, and an ESG working group. This structure integrates sustainability considerations into corporate strategy, business operations and risk management.

The Company has set targets to reach peak carbon emissions by 2030 and achieve net-zero greenhouse gas emissions from its own operations by 2060. In 2025, Yiren Digital published its second consecutive annual ESG Report alongside three ESG-related core policies, including its Occupational Health and Safety Policy, further strengthening its ESG disclosure framework. The Company's ESG reporting now covers more than 90 sub-topics aligned with CSA evaluation criteria.

About Yiren Digital

Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. With the successful filing of the in-house developed Large Language Model Zhiyu, the substantial upgrade of its Magicube Agent platform, Yiren Digital is establishing a new growth engine to position itself as an AI-powered next-generation fintech leader. For more information, please visit https://ir.yiren.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions.

Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of Yiren Digital Ltd. (NYSE: YRD) (the "Company"), and which could cause actual results to differ materially from those expressed or implied in such statements.

Such risks and uncertainties include, but are not limited to, significant fluctuations in loan origination volumes, changes in credit performance and delinquency trends, variations in take rates and monetization efficiency, availability and cost of funding, and the Company's ability to achieve its anticipated financial results or previously issued guidance.

In addition, the Company operates in a highly regulated industry in the People's Republic of China ("PRC"), and its business is materially affected by the evolving regulatory framework applicable to credit facilitation, consumer finance, online lending-related services, data security, and financial risk management. Regulatory policies and implementation measures in these areas have undergone, and may continue to undergo, significant and rapid changes, including changes in interpretation and enforcement.

Such regulatory developments may include, but are not limited to, adjustments to risk retention and capital requirements, restrictions on pricing, interest rates, or service fees, enhanced consumer protection and compliance obligations, data privacy and cybersecurity requirements, and limitations on certain business models or partnership structures. These measures may materially impact the Company's ability to originate loans, maintain relationships with funding partners, price its services competitively, or sustain historical revenue and profitability levels.

Furthermore, the timing, scope, and enforcement intensity of regulatory changes in the PRC are often uncertain and may vary across regions and over time. Such uncertainty may result in increased compliance costs, operational constraints, and strategic adjustments, and may also affect funding partner behavior, borrower demand, and overall industry liquidity.

In addition, shifts in regulatory policy and market expectations may adversely affect investor sentiment and capital market conditions for the industry, potentially resulting in reduced loan facilitation volumes, increased volatility in financial performance, and pressure on margins.

Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors, including, but not limited to, unexpected changes in regulatory policies or enforcement practices, macroeconomic conditions, borrower credit behavior, funding partner participation, competitive dynamics, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission.

All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

SOURCE Yiren Digital
2026-06-12 19:40 1mo ago
2026-04-16 10:00 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. ("Yiren" or the "Company") (NYSE: YRD).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  

The investigation concerns whether Yiren and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 19, 2026, Yiren announced its financial results for the fourth quarter and full year ended December 31, 2025.  Among other items, the Company reported fourth quarter revenue of approximately RMB 957.6 million, representing a decline of approximately 34% year-over-year and significantly below previously issued guidance of RMB 1.4 billion to RMB 1.6 billion.  Yiren also reported a net loss of approximately RMB 882.2 million for the quarter, compared to net income of approximately RMB 331.4 million in the prior-year period.  Yiren further disclosed that its provision for contingent liabilities increased significantly to approximately RMB 1.11 billion, up from approximately RMB 459.8 million in the prior quarter.  The Company also reported worsening delinquency rates across multiple categories, including increases in 1–30 day, 31–60 day, and 61–90 day delinquency rates compared to the prior quarter.  Yiren attributed these results to several factors, including a decline in service fee rates under a new regulatory framework, a strategic reduction in loan facilitation volume, and a higher-risk asset profile. 

On this news, Yiren's American Depositary Receipt ("ADR") price fell $1.65 per ADR, or 44.84%, to close at $2.03 per ADR on March 19, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP
2026-06-12 19:40 1mo ago
2026-04-21 17:09 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Yiren Digital Ltd. – YRD
YRD Yiren Digital
FMP Stock News
Original source text
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. (“Yiren” or the “Company”) (NYSE: YRD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Yiren and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 19, 2026, Yiren announced its financial results for the fourth quarter and full year ended December 31, 2025. Among other items, the Company reported fourth quarter revenue of approximately RMB 957.6 million, representing a decline of approximately 34% year-over-year and significantly below previously issued guidance of RMB 1.4 billion to RMB 1.6 billion. Yiren also reported a net loss of approximately RMB 882.2 million for the quarter, compared to net income of approximately RMB 331.4 million in the prior-year period. Yiren further disclosed that its provision for contingent liabilities increased significantly to approximately RMB 1.11 billion, up from approximately RMB 459.8 million in the prior quarter. The Company also reported worsening delinquency rates across multiple categories, including increases in 1–30 day, 31–60 day, and 61–90 day delinquency rates compared to the prior quarter. Yiren attributed these results to several factors, including a decline in service fee rates under a new regulatory framework, a strategic reduction in loan facilitation volume, and a higher-risk asset profile. 

On this news, Yiren’s American Depositary Receipt (“ADR”) price fell $1.65 per ADR, or 44.84%, to close at $2.03 per ADR on March 19, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
2026-06-12 19:40 1mo ago
2026-04-22 08:00 3mo ago
Yiren Digital to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on April 28, 2026
YRD Yiren Digital
FMP Stock News
Original source text
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced that Mr. William Hui, Chief Financial Officer, will present at the dbVIC – Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on April 28, 2026. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors.

DATE: April 28, 2026
TIME: 11:00 AM ET (11:00 PM Beijing / Hong Kong; 4:00 PM London / Lisbon)
LINK: REGISTER HERE

This will be a live, interactive online event where investors are invited to ask the Company questions in real time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. 

Participation is free of charge.

Recent Company Highlights

AI Transformation & Next-Generation Fintech Strategy: Building upon nearly 20 years of fintech experience and continuous R&D, the Company is positioning itself as a key player in the next generation of AI-driven fintech. In 2025, Yiren Digital completed the regulatory filing for its self-developed Large Language Model (LLM) and, in the second half of the year, launched its first Agentic AI platform, Magicube. This platform leverages the Company's deep industry expertise and the latest AI technologies to drive efficiency and enhance technology monetization. Fiscal Year 2025 Financial Results: Total loans facilitated in 2025 reached RMB67.8 billion (US$9.7 billion), up 26% year-over-year. Credit solution revenue grew 45% yoy to RMB5.0 billion, and the cumulative number of borrowers served reached 14.3 million. The internet insurance distribution business continues to deliver high growth, with new policies rising 68% year-over-year in Q4. S&P Global ESG Recognition: The Company was named to the S&P Global Sustainability Yearbook (China Edition) 2026 and honored with the "Industry Mover" distinction (April 2026). The Company's 2025 Corporate Sustainability Assessment score of 50/100 placed it in the top decile of the "Diversified Financial Services and Capital Markets" industry globally, a 12-point year-over-year improvement. About Yiren Digital

Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. With the successful filing of the in-house developed Large Language Model Zhiyu, the substantial upgrade of its Magicube Agent platform, Yiren Digital is establishing a new growth engine to position itself as an AI-powered next-generation fintech leader. For more information, please visit https://ir.yiren.com.

About Virtual Investor Conferences®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions.

Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of Yiren Digital Ltd. (NYSE: YRD) (the "Company"), and which could cause actual results to differ materially from those expressed or implied in such statements.

Such risks and uncertainties include, but are not limited to, significant fluctuations in loan origination volumes, changes in credit performance and delinquency trends, variations in take rates and monetization efficiency, availability and cost of funding, and the Company's ability to achieve its anticipated financial results or previously issued guidance.

In addition, the Company operates in a highly regulated industry in the People's Republic of China ("PRC"), and its business is materially affected by the evolving regulatory framework applicable to credit facilitation, consumer finance, online lending-related services, data security, and financial risk management. Regulatory policies and implementation measures in these areas have undergone, and may continue to undergo, significant and rapid changes, including changes in interpretation and enforcement.

Such regulatory developments may include, but are not limited to, adjustments to risk retention and capital requirements, restrictions on pricing, interest rates, or service fees, enhanced consumer protection and compliance obligations, data privacy and cybersecurity requirements, and limitations on certain business models or partnership structures. These measures may materially impact the Company's ability to originate loans, maintain relationships with funding partners, price its services competitively, or sustain historical revenue and profitability levels.

Furthermore, the timing, scope, and enforcement intensity of regulatory changes in the PRC are often uncertain and may vary across regions and over time. Such uncertainty may result in increased compliance costs, operational constraints, and strategic adjustments, and may also affect funding partner behavior, borrower demand, and overall industry liquidity.

In addition, shifts in regulatory policy and market expectations may adversely affect investor sentiment and capital market conditions for the industry, potentially resulting in reduced loan facilitation volumes, increased volatility in financial performance, and pressure on margins.

Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors, including, but not limited to, unexpected changes in regulatory policies or enforcement practices, macroeconomic conditions, borrower credit behavior, funding partner participation, competitive dynamics, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission.

All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

SOURCE Yiren Digital
2026-06-12 19:39 1mo ago
2026-04-28 15:31 3mo ago
Yiren Digital Ltd. (YRD) Presents at Deutsche Bank ADR Virtual Investor Conference Transcript
YRD Yiren Digital
FMP Stock News
Original source text
Yiren Digital Ltd. (YRD) Presents at Deutsche Bank ADR Virtual Investor Conference Transcript
2026-06-12 19:39 1mo ago
2026-04-28 21:42 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. (“Yiren” or the “Company”) (NYSE: YRD).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   

The investigation concerns whether Yiren and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 19, 2026, Yiren announced its financial results for the fourth quarter and full year ended December 31, 2025.  Among other items, the Company reported fourth quarter revenue of approximately RMB 957.6 million, representing a decline of approximately 34% year-over-year and significantly below previously issued guidance of RMB 1.4 billion to RMB 1.6 billion.  Yiren also reported a net loss of approximately RMB 882.2 million for the quarter, compared to net income of approximately RMB 331.4 million in the prior-year period.  Yiren further disclosed that its provision for contingent liabilities increased significantly to approximately RMB 1.11 billion, up from approximately RMB 459.8 million in the prior quarter.  The Company also reported worsening delinquency rates across multiple categories, including increases in 1–30 day, 31–60 day, and 61–90 day delinquency rates compared to the prior quarter.  Yiren attributed these results to several factors, including a decline in service fee rates under a new regulatory framework, a strategic reduction in loan facilitation volume, and a higher-risk asset profile. 

On this news, Yiren’s American Depositary Receipt (“ADR”) price fell $1.65 per ADR, or 44.84%, to close at $2.03 per ADR on March 19, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.   

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980 
2026-06-12 19:39 1mo ago
2026-04-30 22:40 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. ("Yiren" or the "Company") (NYSE: YRD).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  

The investigation concerns whether Yiren and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 19, 2026, Yiren announced its financial results for the fourth quarter and full year ended December 31, 2025.  Among other items, the Company reported fourth quarter revenue of approximately RMB 957.6 million, representing a decline of approximately 34% year-over-year and significantly below previously issued guidance of RMB 1.4 billion to RMB 1.6 billion.  Yiren also reported a net loss of approximately RMB 882.2 million for the quarter, compared to net income of approximately RMB 331.4 million in the prior-year period.  Yiren further disclosed that its provision for contingent liabilities increased significantly to approximately RMB 1.11 billion, up from approximately RMB 459.8 million in the prior quarter.  The Company also reported worsening delinquency rates across multiple categories, including increases in 1–30 day, 31–60 day, and 61–90 day delinquency rates compared to the prior quarter.  Yiren attributed these results to several factors, including a decline in service fee rates under a new regulatory framework, a strategic reduction in loan facilitation volume, and a higher-risk asset profile. 

On this news, Yiren's American Depositary Receipt ("ADR") price fell $1.65 per ADR, or 44.84%, to close at $2.03 per ADR on March 19, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP
2026-06-12 19:39 1mo ago
2026-05-07 10:00 2mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yiren Digital Ltd. - YRD
YRD Yiren Digital
FMP Stock News
Original source text
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Yiren Digital Ltd. ("Yiren" or the "Company") (NYSE: YRD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Yiren and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 19, 2026, Yiren announced its financial results for the fourth quarter and full year ended December 31, 2025. Among other items, the Company reported fourth quarter revenue of approximately RMB 957.6 million, representing a decline of approximately 34% year-over-year and significantly below previously issued guidance of RMB 1.4 billion to RMB 1.6 billion. Yiren also reported a net loss of approximately RMB 882.2 million for the quarter, compared to net income of approximately RMB 331.4 million in the prior-year period. Yiren further disclosed that its provision for contingent liabilities increased significantly to approximately RMB 1.11 billion, up from approximately RMB 459.8 million in the prior quarter. The Company also reported worsening delinquency rates across multiple categories, including increases in 1–30 day, 31–60 day, and 61–90 day delinquency rates compared to the prior quarter. Yiren attributed these results to several factors, including a decline in service fee rates under a new regulatory framework, a strategic reduction in loan facilitation volume, and a higher-risk asset profile. 

On this news, Yiren's American Depositary Receipt ("ADR") price fell $1.65 per ADR, or 44.84%, to close at $2.03 per ADR on March 19, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes. 

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP
2026-06-12 19:39 1mo ago
2026-05-14 09:00 2mo ago
Yiren Digital Advances Transition to AI-Native, Multi-Industry Operating Model with Enterprise AI Architecture Rollout
YRD Yiren Digital
FMP Stock News
Original source text
Proprietary Multi-Agent Architecture Enables AI-Driven Execution Across Financial Services and Emerging AI-Native Verticals

, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced that AI is increasingly executing core workflows across its credit and insurance businesses. This shift is improving operating efficiency and unit economics, particularly in customer acquisition and servicing processes, and marks its transition toward an AI-native, multi-industry operating model.

This evolution from AI-assisted operations to agent-driven execution is enabled by Yiren Digital's proprietary AI architecture, which is now deployed across its credit and insurance operations and extending into selected AI-native verticals beyond financial services. The architecture spans a foundation model, a multi-agent platform, an agent execution layer, an enterprise AgentOS, and a workspace-level employee co-pilot.

Under its All-in-AI strategy, the Company is advancing its transition from a technology-enabled financial services platform toward an AI-native, multi-industry operating company. The strategy builds on over 5 years of the Company's purpose-built AI infrastructure and R&D investments, demonstrated operating impact across the Company's credit and insurance businesses, and an AI-executed internet insurance line that has emerged as a second growth engine.

"For years, we have been a fintech company that uses AI to do credit and insurance better," said Mr. Ning Tang, Chairman and Chief Executive Officer of Yiren Digital. "We are now becoming an AI-native, multi-industry company. This shift is already improving how we operate, allowing us to scale expertise, increase efficiency, and expand into new verticals with greater speed and discipline. Our proprietary AI capabilities, developed in one of the most regulated and security-intensive industries in the world, are designed to be portable across financial sub-sectors and adjacent verticals where domain knowledge, data, and agentic execution can scale and compound over time. All-in-AI is how we will operate, grow, and allocate capital from here forward."

From AI-Assisted Tools to AI-Driven Execution

Following the 2025 launch of its proprietary multi-agent platform, MagiCube, the Company's 2026 rollout of MagiCube 2.0 marks a pivotal operational shift. AI agents now function as autonomous executors rather than mere task assistants, delivering end-to-end outcomes across the enterprise lifecycle. Key milestones underpinning this architectural evolution include:

Zhiyu - the Company's proprietary large language model (LLM), received regulatory filing approval in April 2025 and serves as the foundational intelligence layer. MagiCube - the Company's multi-agent integration platform, launched in October 2025 as the connective infrastructure for large-scale agent deployment across sales, risk, capital, compliance, and customer service. MagiCube 2.0 - introduced in 2026, restructures the platform around two specialized layers: XuanJi, for human-and-organization workflow execution, and ZhiNao, the enterprise-wide AgentOS for LLM coordination and multi-agent orchestration. XuanJi: AI-Driven Execution for Labor-Intensive Workflows

XuanJi is the Company's AI-driven workflow execution layer, delivering business outcomes directly across high-volume, repetitive processes including outbound customer service, telesales, insurance proposal generation, lending operations, and post-sale engagement. By moving these functions from human-assisted tasks to agent-delivered results, XuanJi structurally improves cost-to-serve, response speed, and consistency.

ZhiNao: The Enterprise AgentOS

ZhiNao is the Company's centralized orchestration and governance layer, an AgentOS that coordinates LLMs and agents, routes workflows, manages permissions, integrates enterprise knowledge, and enforces AI governance across the organization. ZhiNao serves as the single coordination hub for every agent the Company deploys, internal or third-party, and scales agent-driven operations across knowledge-intensive functions such as advisory services, strategic analysis, and management decision support.

Workspace AI and AI Buddy: A Platform for Human-Agent Collaboration

Workspace AI is the Company's enterprise-wide operating platform connecting employees, AI agents, knowledge systems, and intelligent workflows in a unified execution environment. Its employee-facing interface, AI Buddy, provides every colleague with a personalized co-pilot routed through ZhiNao, a single interface giving frontline staff and management direct access to enterprise data, agentic workflows, and approved third-party AI tools. All agent-driven workflows within the platform operate under a centralized governance framework, ensuring compliance, auditability and risk control across regulated business lines.

A Proven Track Record of AI-Driven Operating Impact

Yiren Digital's All-in-AI strategy has become a core driver of financial performance, delivering enhanced operating leverage across our ecosystem. In fiscal year 2025, integrating proprietary AI agents and LLMs generated meaningful cost efficiencies, and the continued upgrade of the Company's enterprise AI architecture is expected to further accelerate these benefits. Most notably, AI-powered precision marketing has reduced sales & marketing and customer service expenses as a percentage of total revenue. This migration toward an agent-led execution model has fundamentally bolstered our unit economics and positioned the Company for sustainable, profitable growth.

Beyond operational efficiency, our AI infrastructure is a proven engine for rapid business scaling. By repurposing the core AI architecture engineered for our credit operations, our internet insurance distribution business achieved rapid, consecutive-quarter premium growth, becoming an increasingly meaningful revenue contributor. This validates our strategic thesis: a portable AI stack, combined with a massive established user base, creates a structural advantage that drastically accelerates time-to-market. Capitalizing on this momentum, we are advancing an autonomous AI insurance agent assistant, currently in alpha-stage for internal testing. The platform is designed to automate standardized advisory tasks across the insurance customer journey. It will structurally lower customer acquisition costs while freeing up human agents' time to focus more on higher-value client relationship development activities.

Extending All-in-AI Beyond Financial Services: A Capital-Light Ecosystem for Structural AI Growth

Yiren Digital is expanding its All-in-AI strategy through strategic minority investments in high-growth AI startups, further extending its ecosystem. The Company is leveraging its proprietary AI infrastructure and operational experience gained from serving over 14 million cumulative credit customers and more than 2 million insurance customers to support ecosystem partners and emerging AI-native initiatives. By focusing on AI-native verticals where results and benefits drive value, such as AI-enabled learning, interactive entertainment, and autonomous services, this capital-light approach enables the Company to capture structural AI growth while maintaining disciplined capital allocation and limiting execution risk.

According to IDC (International Data Corporation) research, active AI agents deployed by Chinese enterprises are projected to grow at a ~135% CAGR through 2031. This rapid expansion will increasingly favor companies with integrated, agent-orchestrated operating systems over those relying on fragmented point solutions, a trend that aligns with Yiren Digital's architecture and strategy. By unifying intelligence, decision-making, and execution across its proprietary stack, from the Zhiyu foundation model to the ZhiNao AgentOS, Yiren Digital has built a highly scalable architecture. Paired with disciplined capital allocation and a stabilizing credit environment in 2026, this cohesive system is positioned to drive renewed revenue and margin momentum in the periods ahead, supported by continued deployment of agent-driven workflows across its core businesses.

About Yiren Digital

Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. Following the regulatory filing of its in-house developed Large Language Model Zhiyu, and the significant enhancement of its MagiCube Agent platform, Yiren Digital is establishing a new growth engine to accelerate its evolution into an AI-native, multi-industry operating platform extending beyond traditional financial services. For more information, please visit https://ir.yiren.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions.

Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of Yiren Digital Ltd. (NYSE: YRD) (the "Company"), and which could cause actual results to differ materially from those expressed or implied in such statements.

Such risks and uncertainties include, but are not limited to, significant fluctuations in loan origination volumes, changes in credit performance and delinquency trends, variations in take rates and monetization efficiency, availability and cost of funding, and the Company's ability to achieve its anticipated financial results or previously issued guidance.

In addition, the Company operates in a highly regulated industry in the People's Republic of China ("PRC"), and its business is materially affected by the evolving regulatory framework applicable to credit facilitation, consumer finance, online lending-related services, data security, and financial risk management. Regulatory policies and implementation measures in these areas have undergone, and may continue to undergo, significant and rapid changes, including changes in interpretation and enforcement.

Such regulatory developments may include, but are not limited to, adjustments to risk retention and capital requirements, restrictions on pricing, interest rates, or service fees, enhanced consumer protection and compliance obligations, data privacy and cybersecurity requirements, and limitations on certain business models or partnership structures. These measures may materially impact the Company's ability to originate loans, maintain relationships with funding partners, price its services competitively, or sustain historical revenue and profitability levels.

Furthermore, the timing, scope, and enforcement intensity of regulatory changes in the PRC are often uncertain and may vary across regions and over time. Such uncertainty may result in increased compliance costs, operational constraints, and strategic adjustments, and may also affect funding partner behavior, borrower demand, and overall industry liquidity.

In addition, shifts in regulatory policy and market expectations may adversely affect investor sentiment and capital market conditions for the industry, potentially resulting in reduced loan facilitation volumes, increased volatility in financial performance, and pressure on margins.

Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors, including, but not limited to, unexpected changes in regulatory policies or enforcement practices, macroeconomic conditions, borrower credit behavior, funding partner participation, competitive dynamics, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission.

All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

SOURCE Yiren Digital
2026-06-12 19:39 1mo ago
2026-05-26 07:30 2mo ago
Yiren Digital Comments on Recent Media Reports Concerning Affiliates of Its Controlling Shareholder
YRD Yiren Digital
FMP Stock News
Original source text
, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today commented on recent media reports concerning certain financial products offered by affiliates of the Company's controlling shareholder.

Yiren Digital is an independent company listed on the New York Stock Exchange, with its own management team, board of directors, financial reporting and day-to-day operations that are separate from those of its controlling shareholder. The Company's business and strategic focus center on AI-enabled credit and insurance services and technology-driven operations. The Company does not operate in unrelated industries or business sectors.

The matters referenced in the media reports relate to affiliates of the controlling shareholder are not connected to the Company. The Company continues to operate in the normal course of business, and its operations remain unaffected.

Transactions between Yiren Digital and its controlling shareholder and its affiliates are conducted on an arm's-length basis, and are disclosed in the Company's filings in accordance with U.S. Securities and Exchange Commission rules and applicable regulatory requirements.

Yiren Digital remains focused on executing its strategy across AI-enabled financial services, insurance brokerage and technology-driven operations, and is committed to transparent communication with investors and the capital markets. The Company will make any disclosures required under applicable laws, regulations and listing standards as and when appropriate.

About Yiren Digital

Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. Following the regulatory filing of its in-house developed Large Language Model Zhiyu, and the significant enhancement of its MagiCube Agent platform, Yiren Digital is establishing a new growth engine to accelerate its evolution into an AI-native, multi-industry operating platform extending beyond traditional financial services. For more information, please visit https://ir.yiren.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions.

Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of Yiren Digital Ltd. (NYSE: YRD) (the "Company"), and which could cause actual results to differ materially from those expressed or implied in such statements.

Such risks and uncertainties include, but are not limited to, significant fluctuations in loan origination volumes, changes in credit performance and delinquency trends, variations in take rates and monetization efficiency, availability and cost of funding, and the Company's ability to achieve its anticipated financial results or previously issued guidance.

In addition, the Company operates in a highly regulated industry in the People's Republic of China ("PRC"), and its business is materially affected by the evolving regulatory framework applicable to credit facilitation, consumer finance, online lending-related services, data security, and financial risk management. Regulatory policies and implementation measures in these areas have undergone, and may continue to undergo, significant and rapid changes, including changes in interpretation and enforcement.

Such regulatory developments may include, but are not limited to, adjustments to risk retention and capital requirements, restrictions on pricing, interest rates, or service fees, enhanced consumer protection and compliance obligations, data privacy and cybersecurity requirements, and limitations on certain business models or partnership structures. These measures may materially impact the Company's ability to originate loans, maintain relationships with funding partners, price its services competitively, or sustain historical revenue and profitability levels.

Furthermore, the timing, scope, and enforcement intensity of regulatory changes in the PRC are often uncertain and may vary across regions and over time. Such uncertainty may result in increased compliance costs, operational constraints, and strategic adjustments, and may also affect funding partner behavior, borrower demand, and overall industry liquidity.

In addition, shifts in regulatory policy and market expectations may adversely affect investor sentiment and capital market conditions for the industry, potentially resulting in reduced loan facilitation volumes, increased volatility in financial performance, and pressure on margins.

Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors, including, but not limited to, unexpected changes in regulatory policies or enforcement practices, macroeconomic conditions, borrower credit behavior, funding partner participation, competitive dynamics, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission.

All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

SOURCE Yiren Digital Ltd.
2026-06-12 19:39 1mo ago
2026-05-26 08:00 2mo ago
Yiren Digital Expands AI Application-Layer Strategic Investments
YRD Yiren Digital
FMP Stock News
Original source text
Covering AI Entertainment, AI-Assisted Language Learning, and AI Research Productivity

Supported by Structured Investment Options and Future Ownership Rights

, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced the completion of strategic follow-on investments in three early-stage, high-growth AI application companies. These companies operate across emerging artificial intelligence application domains, with a focus on AI entertainment, AI-assisted language learning, and AI research productivity, further expanding the Company's "All-in-AI" ecosystem.

In addition to existing preferred equity positions, the Company has entered into performance-based equity warrants providing the right, but not the obligation, to acquire additional equity interests at pre-agreed valuation terms. Subject to defined performance milestones and payment of consideration, the Company may increase its ownership position, including potentially obtaining majority control in certain portfolio companies.

These arrangements are staged investment rights and do not constitute current control, de facto control, or consolidation. Any future change in ownership will occur only upon satisfaction of contractual conditions and completion of required payments, and all subsequent exercises will be subject to applicable regulatory requirements and corporate governance procedures.

The Company believes artificial intelligence is evolving from foundational infrastructure into large-scale commercial applications that directly shape user behavior and digital experiences, with the application layer expected to be a key long-term value-creation segment across education, media, and consumer-facing verticals.

Through its AI application-layer strategy, the Company invests in early-stage AI businesses close to end users, balancing strategic exposure, capital efficiency, and long-term optionality.

The Company maintains minority positions with staged pathways for potential future ownership increases, enabling participation in the growth of AI-native companies while maintaining disciplined capital allocation. These investments also complement the Company's broader "All-in-AI" transformation and ongoing expansion of its AI capabilities.

Strategic Rationale: Building an Agentic AI Ecosystem

The Company views the AI industry as evolving beyond generative interfaces toward autonomous, context-aware, and action-oriented systems. Agentic AI is expected to become a foundational layer of future digital interaction, enabling AI agents to execute complex tasks and support decision-making across consumer and enterprise environments. Through this lens, Yiren Digital is constructing an interconnected AI application ecosystem designed to generate strategic synergies across content, education, productivity, and entertainment. This approach aims to reinforce user acquisition, data intelligence, and cross-platform monetization over the long term.

Portfolio Overview: Targeting High-Growth Verticals

The newly added portfolio companies represent targeted exposure to distinct, high-growth AI verticals:

An AI-native entertainment company founded by Gen-Z creators that develops interactive storytelling and fan-driven content ecosystems, now building its own IP into a multi-format entertainment universe with strong early user growth and monetization potential. A company aligned with leading AI-driven education platforms and focused on personalized learning at scale. It leverages generative AI to deliver adaptive learning experiences that improve efficiency, accessibility, and user engagement across language and skill development markets, and is highly scalable. A specialized AI education technology company focused on academic productivity. It applies generative AI and knowledge systems to streamline research workflows, improve information validation, and reduce publishing friction, addressing a growing demand for AI-enabled professional research and publication tools in academic area. Strategic Outlook and Enterprise Transformation

Looking ahead, Yiren Digital intends to continue expanding its presence in the AI application economy. Future strategic investments are expected to focus on sectors where the Company believes artificial intelligence can meaningfully change how users learn, interact, and consume content, including intelligent digital engagement platforms, AI-powered media ecosystems, and autonomous workflow systems.

In parallel, the Company continues to advance its enterprise-wide AI transformation. By integrating its proprietary AI architecture and internal agentic workflows with external ecosystem investments, Yiren Digital believes it can participate across multiple layers of AI-driven value creation over the long term.

About Yiren Digital

Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. Following the regulatory filing of its in-house developed Large Language Model Zhiyu, and the significant enhancement of its MagiCube Agent platform, Yiren Digital is establishing a new growth engine to accelerate its evolution into an AI-native, multi-industry operating platform extending beyond traditional financial services. For more information, please visit https://ir.yiren.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions.

Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of Yiren Digital Ltd. (NYSE: YRD) (the "Company"), and which could cause actual results to differ materially from those expressed or implied in such statements.

Such risks and uncertainties include, but are not limited to, significant fluctuations in loan origination volumes, changes in credit performance and delinquency trends, variations in take rates and monetization efficiency, availability and cost of funding, and the Company's ability to achieve its anticipated financial results or previously issued guidance.

In addition, the Company operates in a highly regulated industry in the People's Republic of China ("PRC"), and its business is materially affected by the evolving regulatory framework applicable to credit facilitation, consumer finance, online lending-related services, data security, and financial risk management. Regulatory policies and implementation measures in these areas have undergone, and may continue to undergo, significant and rapid changes, including changes in interpretation and enforcement.

Such regulatory developments may include, but are not limited to, adjustments to risk retention and capital requirements, restrictions on pricing, interest rates, or service fees, enhanced consumer protection and compliance obligations, data privacy and cybersecurity requirements, and limitations on certain business models or partnership structures. These measures may materially impact the Company's ability to originate loans, maintain relationships with funding partners, price its services competitively, or sustain historical revenue and profitability levels.

Furthermore, the timing, scope, and enforcement intensity of regulatory changes in the PRC are often uncertain and may vary across regions and over time. Such uncertainty may result in increased compliance costs, operational constraints, and strategic adjustments, and may also affect funding partner behavior, borrower demand, and overall industry liquidity.

In addition, shifts in regulatory policy and market expectations may adversely affect investor sentiment and capital market conditions for the industry, potentially resulting in reduced loan facilitation volumes, increased volatility in financial performance, and pressure on margins.

Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors, including, but not limited to, unexpected changes in regulatory policies or enforcement practices, macroeconomic conditions, borrower credit behavior, funding partner participation, competitive dynamics, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission.

All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

SOURCE Yiren Digital Ltd.
2026-06-12 19:39 1mo ago
2026-06-08 05:00 1mo ago
Yiren Digital Announces Increase in Beneficial Ownership by Mr. Ning Tang Following Controlling Shareholder Restructuring
YRD Yiren Digital
FMP Stock News
Original source text
, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced that it has been notified by CreditEase Holdings (Cayman) Limited, the Company's controlling shareholder (the "Controlling Shareholder"), that a change in the Controlling Shareholder's shareholding structure took place on June 5, 2026 (the "Restructuring"). As a result of the Restructuring, Mr. Ning Tang, the Company's Executive Chairman and Chief Executive Officer, now beneficially owns the entire equity interests in the Controlling Shareholder. Accordingly, Mr. Ning Tang's indirect beneficial ownership of the Company's ordinary shares has increased from approximately 35.6% to approximately 82.0% of the total issued and outstanding ordinary shares of the Company. Prior to the Restructuring, Mr. Ning Tang held a 43.4% equity interest in the Controlling Shareholder.

The Restructuring relates solely to the ownership structure of the Controlling Shareholder and does not result in any change to the Company's day-to-day operations, management, business strategy, or corporate governance.

About Yiren Digital

Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. With the successful filing of the in-house developed Large Language Model Zhiyu, the substantial upgrade of its Magicube Agent platform, Yiren Digital is establishing a new growth engine to position itself as an AI-powered next-generation fintech leader. For more information, please visit https://ir.yiren.com.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "aim," "anticipate," "believe," "estimate," "expect," "hope," "going forward," "intend," "ought to," "plan," "project," "potential," "seek," "may," "might," "can," "could," "will," "would," "shall," "should," "is likely to" and the negative form of these words and other similar expressions. This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions. Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of the Company, and which could cause actual results to differ materially from those expressed or implied in such statements. Potential risks and uncertainties include, but are not limited to, unexpected changes in regulatory policies or enforcement practices, macroeconomic conditions, borrower credit behavior, funding partner participation, competitive dynamics, the Company's ability to achieve its anticipated financial results or previously issued guidance, and the Company's ability to meet the standards necessary to maintain listing of its ADSs on the NYSE, including its ability to cure any non-compliance with the NYSE's continued listing criteria. Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

SOURCE Yiren Digital Ltd.
2026-06-12 19:39 1mo ago
2026-04-29 17:15 3mo ago
Yatsen Filed 2025 Annual Report on Form 20-F
YSG Yatsen Holding
FMP Stock News
Original source text
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that the Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC") on April 29, 2026.

The annual report is available on the Company's investor relations website at ir.yatsenglobal.com and on the SEC's website at https://www.sec.gov/. The Company will provide hard copies of the annual report, free of charge, to its shareholders and ADS holders upon written request. Requests should be directed to Investor Relations Department, Yatsen Holding Limited, Floor 39, Poly Development Plaza, No. 832 Yue Jiang Zhong Road, Haizhu District, Guangzhou 510335, People's Republic of China.

About Yatsen Holding Limited

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.

For more information, please visit http://ir.yatsenglobal.com/.

For investor and media inquiries, please contact:

Yatsen Holding Limited
Investor Relations
E-mail: [email protected]

SOURCE Yatsen Holding Limited
2026-06-12 19:39 1mo ago
2026-05-07 03:00 2mo ago
Yatsen's $100 Million R&D Investment Wins Consumer Trust and Market Share
YSG Yatsen Holding
FMP Stock News
Original source text
, /PRNewswire/ -- In a significant shift reshaping the global beauty industry, Chinese domestic cosmetics brands have captured nearly 60% of the world's second-largest beauty market. This shift is being driven by unprecedented investments in scientific innovation, as well as rapidly evolving consumer expectations. Yatsen Group, one of China's leading beauty companies, today highlighted how its approximately $100 million (RMB 700 million) in R&D investment since 2020 exemplifies the industry's transformation from price-based competition to technology-driven excellence.

Cheng Jing, Chief Scientific Officer of Yatsen Group, during an interview with CGTN (China Global Television Network)

Yatsen Global Innovation R&D Center Over the past decade, Chinese beauty companies have fundamentally strengthened their competitive position, with market share surging from 43% in 2015, according to Frost & Sullivan, to 57% in 2024, according to Xinhua News. This growth reflects a broader consumer evolution: Chinese beauty shoppers are increasingly prioritizing proven efficacy, scientific credibility, and innovation, a shift that domestic brands have actively capitalized on by ramping up investment in R&D and innovation to respond quickly to changing preferences.

As a result, Chinese cosmetics brands are moving away from reliance on cost competition toward building a long-term technological and brand advantage on the global stage.

"This growth is primarily driven by continuous advancements in innovation, brand equity, and product use experience," said Cheng Jing, Chief Scientific Officer of Yatsen Group. "Chinese consumers have become more sophisticated. Their focus has shifted from price to proven efficacy, safety, scientific credibility, and cultural identity."

Importantly, this transformation extends far beyond marketing. Leading Chinese beauty companies are constructing world-class innovation ecosystems.

Yatsen's "1-3-4-6-20" global innovation strategy encompasses three research centers across Shanghai, Guangzhou, and Toulouse, France, with over half of its R&D team holding master's or PhD degrees. The company maintains six joint research laboratories and more than 20 collaborative programs with prestigious institutions including Saint-Louis Hospital in France, as well as Ruijin Hospital, Sun Yat-sen University and Fudan University in China.

"The industry is moving from supply-chain-driven 'product globalization' to innovation-led 'brand globalization,'" added Cheng Jing. "Looking ahead, our goal is to be a world-class beauty innovation pioneer, utilizing a resilient supply chain and 'Glocal' agility to meet the needs of sophisticated consumers worldwide."

This scientific infrastructure addresses what industry analysts identify as the new consumer mandate: products that deliver measurable results backed by rigorous research.

This focus is reflected in Yatsen's portfolio: Perfect Diary leads the emerging "makeup skinification" trend, DR.WU delivers clinic-grade skin renewal, Galénic focuses on cellular-level anti-aging science and Eve Lom leverages advanced neuroscience for emotional skincare benefits.

Global Ambitions, Local Insights

The domestic market success is proving to be a launchpad for international expansion. Since 2021, Yatsen's flagship brand Perfect Diary has gained traction in Southeast Asia and Japan. Its loose powder has consistently ranked among the top three in its category on major e-commerce platforms, according to data from Qoo10 Japan, Amazon Japan, Shopee Vietnam, and TikTok Vietnam—demonstrating that Chinese innovation can compete on performance.

According to one full year of continuous tracking data by Frost & Sullivan, Perfect Diary Biolip Essence Lipstick has been officially recognized as the top-selling lipstick SKU by a Chinese brand worldwide. This achievement stands as a significant milestone showcasing the global rise of technological innovation among Chinese brands.

According to CGTN, Chinese beauty companies are well positioned to benefit from the global shift toward a dual emphasis on efficacy and emotional value. With complete innovation capabilities spanning raw materials to finished products, and supply chain agility that enables rapid response to market trends, domestic brands have transformed former weaknesses into competitive advantages.

About Yatsen Group

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.

Email: [email protected]
Website: www.yatsenglobal.com
LinkedIn: www.linkedin.com/company/yatsen

SOURCE Yatsen Holding Limited
2026-06-12 19:39 1mo ago
2026-05-19 05:00 2mo ago
Yatsen to Announce First Quarter 2026 Financial Results on May 26, 2026
YSG Yatsen Holding
FMP Stock News
Original source text
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it will release its unaudited financial results for the first quarter of 2026, on Tuesday, May 26, 2026, before the open of the U.S. markets.

The Company's management will hold a conference call on Tuesday, May 26, 2026 at 7:30 A.M. U.S. Eastern Time (7:30 P.M. Beijing/Hong Kong Time) to discuss the financial results. Listeners may access the call by dialing the following numbers:

United States (toll free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (toll free):

400-120-1203

Hong Kong (toll free):

800-905-945

Hong Kong:

+852-3018-4992

A live and archived webcast of the conference call will be available on the Company's investor relations website at http://ir.yatsenglobal.com.

A replay of the conference call will be accessible by phone one hour after the conclusion of the live call at the following numbers, until June 2, 2026:

United States:

+1-855-669-9658

International:

+1-412-317-0088

Replay Access Code:

4359154

About Yatsen Holding Limited

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.

For more information, please visit http://ir.yatsenglobal.com.

For investor and media inquiries, please contact:

Yatsen Holding Limited
Investor Relations
E-mail: [email protected]

SOURCE Yatsen Holding Limited
2026-06-12 19:39 1mo ago
2026-05-21 06:00 2mo ago
Yatsen Announces Completion of First Tranche in Previously Announced Private Placement and Hillhouse Participation
YSG Yatsen Holding
FMP Stock News
Original source text
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced the participation of Hillhouse in the Company's previously announced private placement of RMB-denominated convertible senior notes and warrants (the "Transaction"), and the completion of the first tranche of the Transaction.

Certain affiliates of Hillhouse have joined the investment vehicle for the Transaction (the "Purchaser") as a co-investor, alongside Trustar Capital and Mr. Jinfeng Huang, the Company's founder, Chairman and Chief Executive Officer. The Company and the Purchaser have entered into an amendment to the original note purchase agreement to reflect the expanded investor base.

The closing of the first tranche of the notes (the "First Note") and the corresponding warrants occurred on May 21, 2026. Subject to the satisfaction of applicable closing conditions, the second tranche of the notes is currently expected to be issued later this year. The total aggregate principal amount of the two equal tranches of notes remains unchanged at equivalent to approximately US$120 million. The Company continues to intend to use the net proceeds from the Transaction for product research and development, global supply chain integration, overseas market expansion, strategic mergers and acquisitions, and general corporate purposes.

Mr. Jinfeng Huang, Founder, Chairman and CEO of Yatsen, stated: "We are pleased to welcome Hillhouse's participation in the Transaction. As one of Yatsen's largest and longest-standing shareholders, Hillhouse has supported the Company since 2018. Their continued commitment, together with Trustar Capital and my personal participation, reflects strong confidence in Yatsen's long-term value and strategic direction. With the completion of the first tranche, we are better positioned to execute our growth strategy and create lasting value for shareholders over the long term."

The issuance of the securities under the Transaction has not been registered and is exempt from registration under the Securities Act of 1933, as amended. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.

About Yatsen Holding Limited

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom.

For more information, please visit http://ir.yatsenglobal.com/.

Safe Harbor Statement

This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Yatsen Holding Limited
Investor Relations
E-mail: [email protected]

SOURCE Yatsen Holding Limited
2026-06-12 19:39 1mo ago
2026-05-26 05:00 2mo ago
Yatsen Announces First Quarter 2026 Financial Results
YSG Yatsen Holding
FMP Stock News
Original source text
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on May 26, 2026

, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended March 31, 2026.

First Quarter 2026 Highlights

Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. Total net revenues from Skincare Brands[1] for the first quarter increased by 58.5% to RMB574.2 million (US$83.2 million) from RMB362.4 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the first quarter of 2026 were 56.2%, as compared with 43.5% for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period. Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Non-GAAP net loss[2] for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "For the first quarter of 2026, we delivered top-line growth that met our previous guidance and demonstrated the ongoing resilience of our multi-brand strategy. Our growth this quarter was primarily propelled by the sustained upward momentum of our Skincare Brands, which experienced substantial year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that we completed the first closing of our private placement of convertible notes and warrants in an aggregate principal amount equivalent to approximately US$120 million, with participation from Trustar Capital, Hillhouse and myself, on May 21, 2026. This successful closing serves as a powerful testament to our shareholders' long-term confidence in Yatsen's strategic direction and future value."

Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our financial results for the first quarter of 2026 reflect encouraging progress in the expansion of our core brands. Total net revenues from our Skincare Brands delivered robust growth, while the combined net revenues of our three major premium and clinical skincare brands, Galénic, DR.WU and Eve Lom, grew by 61.4% year over year. Our gross margin continued its year-over-year expansion and reached 80.2%. This underlying strength underscores the structural health of our business model. While we selectively deployed resources to scale and strengthen our core brands, our commitment to long-term profitability optimization remains unwavering. Moving forward, we are focused on cost optimization to ensure that our top-line expansion efficiently translates into future margin improvement."

First Quarter 2026 Financial Results

Net Revenues

Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. The increase was primarily due to a 58.5% year-over-year increase in net revenues from Skincare Brands, partially offset by a 5.0% year-over-year decrease in net revenues from Color Cosmetics Brands.[3]

Gross Profit and Gross Margin

Gross profit for the first quarter of 2026 increased by 24.3% to RMB819.2 million (US$118.8 million) from RMB659.1 million for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.

Operating Expenses

Total operating expenses for the first quarter of 2026 increased by 32.5% to RMB918.1 million (US$133.1 million) from RMB693.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the first quarter of 2026 were 89.9%, as compared with 83.2% for the prior year period.

Fulfillment Expenses. Fulfillment expenses for the first quarter of 2026 were RMB61.1 million (US$8.9 million), as compared with RMB51.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the first quarter of 2026 decreased to 6.0% from 6.2% for the prior year period. The decrease was primarily due to further improvements in logistics efficiency. Selling and Marketing Expenses. Selling and marketing expenses for the first quarter of 2026 were RMB737.2 million (US$106.9 million), as compared with RMB553.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the first quarter of 2026 increased to 72.2% from 66.4% for the prior year period. The increase was primarily driven by investments in broadening consumer awareness and building long-term brand equity of our core brands, coupled with higher traffic acquisition costs on the Douyin platform. General and Administrative Expenses. General and administrative expenses for the first quarter of 2026 were RMB80.3 million (US$11.6 million), as compared with RMB64.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the first quarter of 2026 were 7.9% as compared with 7.8% for the prior year period, remaining largely flat. Research and Development Expenses. Research and development expenses for the first quarter of 2026 were RMB39.4 million (US$5.7 million), as compared with RMB22.6 million for the prior year period. As a percentage of total net revenues, research and development expenses for the first quarter of 2026 increased to 3.9% from 2.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount. Loss / Income from Operations

Loss from operations for the first quarter of 2026 was RMB99.0 million (US$14.3 million), as compared with RMB34.1 million for the prior year period. Operating loss margin was 9.7%, as compared with 4.1% for the prior year period.

Non-GAAP loss from operations[4] for the first quarter of 2026 was RMB84.6 million (US$12.3 million), as compared with RMB14.9 million for the prior year period. Non-GAAP operating loss margin[5] was 8.3%, as compared with 1.8% for the prior year period.

Net Loss / Income

Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Net loss margin was 6.1%, as compared with 0.7% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the first quarter of 2026 was RMB0.64 (US$0.09), as compared with RMB0.06 for the prior year period.

Non-GAAP net loss for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the first quarter of 2026 was RMB0.60 (US$0.09), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.07 for the prior year period.

Balance Sheet and Cash Flow

As of March 31, 2026, the Company had cash, restricted cash and short-term investments of RMB934.2 million (US$135.4 million), as compared with RMB1.05 billion as of December 31, 2025.

Net cash used in operating activities for the first quarter of 2026 was RMB90.0 million (US$13.0 million), as compared with net cash generated from operating activities of RMB23.8 million for the prior year period.

Business Outlook

For the second quarter of 2026, the Company expects its total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.

Exchange Rate

This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.8980 to US$1.00, the exchange rate in effect as of March 31, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.

[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.

[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.

[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.

[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.

[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.

[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.

[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.

Conference Call Information

The Company's management will hold a conference call on Tuesday, May 26, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the first quarter of 2026.

United States (toll free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (toll free):

400-120-1203

Hong Kong, SAR (toll free):

800-905-945

Hong Kong, SAR:

+852-3018-4992

The replay will be accessible through Tuesday, June 2, by dialing the following numbers:

United States:

+1-855-669-9658

International:

+1-412-317-0088

Replay Access Code:

4359154

A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.

About Yatsen Holding Limited

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.

For more information, please visit http://ir.yatsenglobal.com.

Use of Non-GAAP Financial Measures

The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.

However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.

Safe Harbor Statement

This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Yatsen Holding Limited
Investor Relations
E-mail: [email protected]

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(All amounts in thousands, except for share, per share data or otherwise noted)

December 31,

March 31,

March 31,

2025

2026

2026

RMB'000

RMB'000

USD'000

Assets

Current assets

Cash and cash equivalents

765,379

876,144

127,014

Restricted Cash

42,117

58,036

8,413

Short-term investments

246,008

-

-

Accounts receivable, net

220,870

183,701

26,631

Inventories, net

508,730

573,339

83,117

Prepayments and other current assets

450,970

440,103

63,802

Amounts due from related parties

114

53

8

Total current assets

2,234,188

2,131,376

308,985

Non-current assets

Investments

653,560

667,995

96,839

Property and equipment, net

77,014

71,982

10,435

Goodwill, net

155,029

155,029

22,474

Intangible assets, net

537,509

509,249

73,826

Deferred tax assets

1,435

1,040

151

Right-of-use assets, net

173,915

158,718

23,009

Other non-current assets

14,332

22,151

3,211

Total non-current assets

1,612,794

1,586,164

229,945

Total assets

3,846,982

3,717,540

538,930

Liabilities, redeemable non-controlling interests and shareholders'
equity

Current liabilities

Accounts and notes payable

149,371

154,805

22,442

Advances from customers

28,821

29,480

4,274

Accrued expenses and other liabilities

348,700

322,994

46,824

Amounts due to related parties

21,262

19,412

2,814

Income tax payables

13,690

13,778

1,997

Lease liabilities due within one year

53,435

53,039

7,689

Total current liabilities

615,279

593,508

86,040

Non-current liabilities

Deferred tax liabilities

107,906

106,052

15,374

Lease liabilities

123,157

110,184

15,973

Total non-current liabilities

231,063

216,236

31,347

Total liabilities

846,342

809,744

117,387

Redeemable non-controlling interests

1,337

1,337

194

Shareholders' equity

Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary
shares authorized, comprising of 6,000,000,000 Class A ordinary
shares, 960,852,606 Class B ordinary shares and 3,039,147,394
shares each of such classes to be designated as of December 31,
2025 and March 31, 2026; 2,096,600,883 Class A shares and
600,572,880 Class B ordinary shares issued as of December 31,
2025 and March 31, 2026; 1,276,663,163 Class A ordinary shares
and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2025, 1,275,536,483 Class A ordinary shares and
600,572,880 Class B ordinary shares outstanding as of March 31,
2026)

173

173

25

Treasury shares

(1,250,678)

(1,253,378)

(181,702)

Additional paid-in capital

12,296,367

12,297,001

1,782,691

Statutory reserve

31,527

31,527

4,570

Accumulated deficit

(8,141,545)

(8,202,059)

(1,189,049)

Accumulated other comprehensive income

74,760

45,910

6,657

Total Yatsen Holding Limited shareholders' equity

3,010,604

2,919,174

423,192

Non-controlling interests

(11,301)

(12,715)

(1,843)

Total shareholders' equity

2,999,303

2,906,459

421,349

Total liabilities, redeemable non-controlling interests and
shareholders' equity

3,846,982

3,717,540

538,930

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(All amounts in thousands, except for share, per share data or otherwise noted)

For the Three Months Ended March 31,

2025

2026

2026

RMB'000

RMB'000

USD'000

Total net revenues

833,533

1,020,986

148,012

Total cost of revenues

(174,406)

(201,797)

(29,254)

Gross profit

659,127

819,189

118,758

Operating expenses:

Fulfilment expenses

(51,843)

(61,138)

(8,863)

Selling and marketing expenses

(553,815)

(737,236)

(106,877)

General and administrative expenses

(64,883)

(80,326)

(11,645)

Research and development expenses

(22,637)

(39,440)

(5,718)

Total operating expenses

(693,178)

(918,140)

(133,103)

Loss from operations

(34,051)

(98,951)

(14,345)

Financial income

10,606

10,741

1,557

Foreign currency exchange gain (loss)

10,664

(3,198)

(464)

Income from equity method investments, net

2,505

12,389

1,796

Other income, net

4,242

18,466

2,677

Loss before income tax expenses

(6,034)

(60,553)

(8,779)

Income tax benefits (expenses)

433

(1,375)

(199)

Net loss

(5,601)

(61,928)

(8,978)

Net loss attributable to non-controlling interests and redeemable non-
controlling interests

298

1,414

205

Net loss attributable to Yatsen's shareholders

(5,303)

(60,514)

(8,773)

Shares used in calculating loss per share (1):

Weighted average number of Class A and Class B ordinary shares:

    Basic

1,837,466,068

1,876,901,662

1,876,901,662

    Diluted

1,837,466,068

1,876,901,662

1,876,901,662

Net loss per Class A and Class B ordinary share

    Basic

(0.00)

(0.03)

(0.00)

    Diluted

(0.00)

(0.03)

(0.00)

Net loss per ADS (20 ordinary shares equal to 1 ADS) (2)

    Basic

(0.06)

(0.64)

(0.09)

    Diluted

(0.06)

(0.64)

(0.09)

For the Three Months Ended March 31,

2025

2026

2026

Share-based compensation expenses are included in the
operating expenses as follows:

RMB'000

RMB'000

USD'000

Fulfilment expenses

98

249

36

Selling and marketing expenses

757

148

21

General and administrative expenses

7,731

2,003

290

Research and development expenses

40

1,159

168

Total

8,626

3,559

515

(1)  Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each
Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that
are subject to shareholder vote.

YATSEN HOLDING LIMITED

UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS

(All amounts in thousands, except for share, per share data or otherwise noted)

For the Three Months Ended March 31,

2025

2026

2026

RMB'000

RMB'000

USD'000

Loss from operations

(34,051)

(98,951)

(14,345)

Share-based compensation expenses

8,626

3,559

515

Amortization of intangible assets resulting from assets and business
acquisitions

10,561

10,759

1,560

Non-GAAP loss from operations

(14,864)

(84,633)

(12,270)

Net loss

(5,601)

(61,928)

(8,978)

Share-based compensation expenses

8,626

3,559

515

Amortization of intangible assets resulting from assets and business
acquisitions

10,561

10,759

1,560

Revaluation of investments on the share of equity method
investments

(6,010)

(10,469)

(1,518)

Tax effects on non-GAAP adjustments

(433)

829

120

Non-GAAP net income (loss)

7,143

(57,250)

(8,301)

Net loss attributable to Yatsen's shareholders

(5,303)

(60,514)

(8,773)

Share-based compensation expenses

8,626

3,559

515

Amortization of intangible assets resulting from assets and business
acquisitions

10,179

10,473

1,518

Revaluation of investments on the share of equity method
investments

(6,010)

(10,469)

(1,518)

Tax effects on non-GAAP adjustments

(405)

829

120

Non-GAAP net income (loss) attributable to Yatsen's
shareholders

7,087

(56,122)

(8,138)

Shares used in calculating loss per share:

Weighted average number of Class A and Class B ordinary shares:

    Basic

1,837,466,068

1,876,901,662

1,876,901,662

    Diluted

1,953,491,427

1,876,901,662

1,876,901,662

Non-GAAP net income (loss) attributable to ordinary
shareholders per Class A and Class B ordinary share

    Basic

0.00

(0.03)

(0.00)

    Diluted

0.00

(0.03)

(0.00)

Non-GAAP net income (loss) attributable to ordinary
shareholders per ADS (20 ordinary shares equal to 1 ADS) (1)

    Basic

0.08

(0.60)

(0.09)

    Diluted

0.07

(0.60)

(0.09)

SOURCE Yatsen Holding Limited
2026-06-12 19:39 1mo ago
2026-05-26 06:00 2mo ago
Yatsen Announces First Quarter 2026 Financial Results
YSG Yatsen Holding
FMP Stock News
Original source text
Yatsen Announces First Quarter 2026 Financial Results PR Newswire

GUANGZHOU, China, May 26, 2026

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on May 26, 2026

, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended March 31, 2026.

First Quarter 2026 Highlights

Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period.Total net revenues from Skincare Brands[1] for the first quarter increased by 58.5% to RMB574.2 million (US$83.2 million) from RMB362.4 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the first quarter of 2026 were 56.2%, as compared with 43.5% for the prior year period.Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Non-GAAP net loss[2] for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period.Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "For the first quarter of 2026, we delivered top-line growth that met our previous guidance and demonstrated the ongoing resilience of our multi-brand strategy. Our growth this quarter was primarily propelled by the sustained upward momentum of our Skincare Brands, which experienced substantial year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that we completed the first closing of our private placement of convertible notes and warrants in an aggregate principal amount equivalent to approximately US$120 million, with participation from Trustar Capital, Hillhouse and myself, on May 21, 2026. This successful closing serves as a powerful testament to our shareholders' long-term confidence in Yatsen's strategic direction and future value."

Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our financial results for the first quarter of 2026 reflect encouraging progress in the expansion of our core brands. Total net revenues from our Skincare Brands delivered robust growth, while the combined net revenues of our three major premium and clinical skincare brands, Galénic, DR.WU and Eve Lom, grew by 61.4% year over year. Our gross margin continued its year-over-year expansion and reached 80.2%. This underlying strength underscores the structural health of our business model. While we selectively deployed resources to scale and strengthen our core brands, our commitment to long-term profitability optimization remains unwavering. Moving forward, we are focused on cost optimization to ensure that our top-line expansion efficiently translates into future margin improvement."

First Quarter 2026 Financial Results

Net Revenues

Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. The increase was primarily due to a 58.5% year-over-year increase in net revenues from Skincare Brands, partially offset by a 5.0% year-over-year decrease in net revenues from Color Cosmetics Brands.[3]

Gross Profit and Gross Margin

Gross profit for the first quarter of 2026 increased by 24.3% to RMB819.2 million (US$118.8 million) from RMB659.1 million for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.

Operating Expenses

Total operating expenses for the first quarter of 2026 increased by 32.5% to RMB918.1 million (US$133.1 million) from RMB693.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the first quarter of 2026 were 89.9%, as compared with 83.2% for the prior year period.

Fulfillment Expenses. Fulfillment expenses for the first quarter of 2026 were RMB61.1 million (US$8.9 million), as compared with RMB51.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the first quarter of 2026 decreased to 6.0% from 6.2% for the prior year period. The decrease was primarily due to further improvements in logistics efficiency.Selling and Marketing Expenses. Selling and marketing expenses for the first quarter of 2026 were RMB737.2 million (US$106.9 million), as compared with RMB553.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the first quarter of 2026 increased to 72.2% from 66.4% for the prior year period. The increase was primarily driven by investments in broadening consumer awareness and building long-term brand equity of our core brands, coupled with higher traffic acquisition costs on the Douyin platform.General and Administrative Expenses. General and administrative expenses for the first quarter of 2026 were RMB80.3 million (US$11.6 million), as compared with RMB64.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the first quarter of 2026 were 7.9% as compared with 7.8% for the prior year period, remaining largely flat.Research and Development Expenses. Research and development expenses for the first quarter of 2026 were RMB39.4 million (US$5.7 million), as compared with RMB22.6 million for the prior year period. As a percentage of total net revenues, research and development expenses for the first quarter of 2026 increased to 3.9% from 2.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount.Loss / Income from Operations

Loss from operations for the first quarter of 2026 was RMB99.0 million (US$14.3 million), as compared with RMB34.1 million for the prior year period. Operating loss margin was 9.7%, as compared with 4.1% for the prior year period.

Non-GAAP loss from operations[4] for the first quarter of 2026 was RMB84.6 million (US$12.3 million), as compared with RMB14.9 million for the prior year period. Non-GAAP operating loss margin[5] was 8.3%, as compared with 1.8% for the prior year period.

Net Loss / Income

Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Net loss margin was 6.1%, as compared with 0.7% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the first quarter of 2026 was RMB0.64 (US$0.09), as compared with RMB0.06 for the prior year period.

Non-GAAP net loss for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the first quarter of 2026 was RMB0.60 (US$0.09), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.07 for the prior year period.

Balance Sheet and Cash Flow

As of March 31, 2026, the Company had cash, restricted cash and short-term investments of RMB934.2 million (US$135.4 million), as compared with RMB1.05 billion as of December 31, 2025.

Net cash used in operating activities for the first quarter of 2026 was RMB90.0 million (US$13.0 million), as compared with net cash generated from operating activities of RMB23.8 million for the prior year period.

Business Outlook

For the second quarter of 2026, the Company expects its total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.

Exchange Rate

This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.8980 to US$1.00, the exchange rate in effect as of March 31, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.

[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.

[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.

[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.

[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.

[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.

[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.

[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.

Conference Call Information

The Company's management will hold a conference call on Tuesday, May 26, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the first quarter of 2026.

United States (toll free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (toll free):

400-120-1203

Hong Kong, SAR (toll free):

800-905-945

Hong Kong, SAR:

+852-3018-4992

The replay will be accessible through Tuesday, June 2, by dialing the following numbers:

United States:

+1-855-669-9658

International:

+1-412-317-0088

Replay Access Code:

4359154

A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.

About Yatsen Holding Limited

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.

For more information, please visit http://ir.yatsenglobal.com.

Use of Non-GAAP Financial Measures

The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.

However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.

Safe Harbor Statement

This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Yatsen Holding Limited
Investor Relations
E-mail: [email protected]

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(All amounts in thousands, except for share, per share data or otherwise noted)

December 31,

March 31,

March 31,

2025

2026

2026

RMB'000

RMB'000

USD'000

Assets

Current assets

Cash and cash equivalents

765,379

876,144

127,014

Restricted Cash

42,117

58,036

8,413

Short-term investments

246,008

-

-

Accounts receivable, net

220,870

183,701

26,631

Inventories, net

508,730

573,339

83,117

Prepayments and other current assets

450,970

440,103

63,802

Amounts due from related parties

114

53

8

Total current assets

2,234,188

2,131,376

308,985

Non-current assets

Investments

653,560

667,995

96,839

Property and equipment, net

77,014

71,982

10,435

Goodwill, net

155,029

155,029

22,474

Intangible assets, net

537,509

509,249

73,826

Deferred tax assets

1,435

1,040

151

Right-of-use assets, net

173,915

158,718

23,009

Other non-current assets

14,332

22,151

3,211

Total non-current assets

1,612,794

1,586,164

229,945

Total assets

3,846,982

3,717,540

538,930

Liabilities, redeemable non-controlling interests and shareholders'
equity

Current liabilities

Accounts and notes payable

149,371

154,805

22,442

Advances from customers

28,821

29,480

4,274

Accrued expenses and other liabilities

348,700

322,994

46,824

Amounts due to related parties

21,262

19,412

2,814

Income tax payables

13,690

13,778

1,997

Lease liabilities due within one year

53,435

53,039

7,689

Total current liabilities

615,279

593,508

86,040

Non-current liabilities

Deferred tax liabilities

107,906

106,052

15,374

Lease liabilities

123,157

110,184

15,973

Total non-current liabilities

231,063

216,236

31,347

Total liabilities

846,342

809,744

117,387

Redeemable non-controlling interests

1,337

1,337

194

Shareholders' equity

Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary
shares authorized, comprising of 6,000,000,000 Class A ordinary
shares, 960,852,606 Class B ordinary shares and 3,039,147,394
shares each of such classes to be designated as of December 31,
2025 and March 31, 2026; 2,096,600,883 Class A shares and
600,572,880 Class B ordinary shares issued as of December 31,
2025 and March 31, 2026; 1,276,663,163 Class A ordinary shares
and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2025, 1,275,536,483 Class A ordinary shares and
600,572,880 Class B ordinary shares outstanding as of March 31,
2026)

173

173

25

Treasury shares

(1,250,678)

(1,253,378)

(181,702)

Additional paid-in capital

12,296,367

12,297,001

1,782,691

Statutory reserve

31,527

31,527

4,570

Accumulated deficit

(8,141,545)

(8,202,059)

(1,189,049)

Accumulated other comprehensive income

74,760

45,910

6,657

Total Yatsen Holding Limited shareholders' equity

3,010,604

2,919,174

423,192

Non-controlling interests

(11,301)

(12,715)

(1,843)

Total shareholders' equity

2,999,303

2,906,459

421,349

Total liabilities, redeemable non-controlling interests and
shareholders' equity

3,846,982

3,717,540

538,930

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(All amounts in thousands, except for share, per share data or otherwise noted)

For the Three Months Ended March 31,

2025

2026

2026

RMB'000

RMB'000

USD'000

Total net revenues

833,533

1,020,986

148,012

Total cost of revenues

(174,406)

(201,797)

(29,254)

Gross profit

659,127

819,189

118,758

Operating expenses:

Fulfilment expenses

(51,843)

(61,138)

(8,863)

Selling and marketing expenses

(553,815)

(737,236)

(106,877)

General and administrative expenses

(64,883)

(80,326)

(11,645)

Research and development expenses

(22,637)

(39,440)

(5,718)

Total operating expenses

(693,178)

(918,140)

(133,103)

Loss from operations

(34,051)

(98,951)

(14,345)

Financial income

10,606

10,741

1,557

Foreign currency exchange gain (loss)

10,664

(3,198)

(464)

Income from equity method investments, net

2,505

12,389

1,796

Other income, net

4,242

18,466

2,677

Loss before income tax expenses

(6,034)

(60,553)

(8,779)

Income tax benefits (expenses)

433

(1,375)

(199)

Net loss

(5,601)

(61,928)

(8,978)

Net loss attributable to non-controlling interests and redeemable non-
controlling interests

298

1,414

205

Net loss attributable to Yatsen's shareholders

(5,303)

(60,514)

(8,773)

Shares used in calculating loss per share (1):

Weighted average number of Class A and Class B ordinary shares:

Basic

1,837,466,068

1,876,901,662

1,876,901,662

Diluted

1,837,466,068

1,876,901,662

1,876,901,662

Net loss per Class A and Class B ordinary share

Basic

(0.00)

(0.03)

(0.00)

Diluted

(0.00)

(0.03)

(0.00)

Net loss per ADS (20 ordinary shares equal to 1 ADS) (2)

Basic

(0.06)

(0.64)

(0.09)

Diluted

(0.06)

(0.64)

(0.09)

For the Three Months Ended March 31,

2025

2026

2026

Share-based compensation expenses are included in the
operating expenses as follows:

RMB'000

RMB'000

USD'000

Fulfilment expenses

98

249

36

Selling and marketing expenses

757

148

21

General and administrative expenses

7,731

2,003

290

Research and development expenses

40

1,159

168

Total

8,626

3,559

515

(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each
Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that
are subject to shareholder vote.

YATSEN HOLDING LIMITED

UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS

(All amounts in thousands, except for share, per share data or otherwise noted)

For the Three Months Ended March 31,

2025

2026

2026

RMB'000

RMB'000

USD'000

Loss from operations

(34,051)

(98,951)

(14,345)

Share-based compensation expenses

8,626

3,559

515

Amortization of intangible assets resulting from assets and business
acquisitions

10,561

10,759

1,560

Non-GAAP loss from operations

(14,864)

(84,633)

(12,270)

Net loss

(5,601)

(61,928)

(8,978)

Share-based compensation expenses

8,626

3,559

515

Amortization of intangible assets resulting from assets and business
acquisitions

10,561

10,759

1,560

Revaluation of investments on the share of equity method
investments

(6,010)

(10,469)

(1,518)

Tax effects on non-GAAP adjustments

(433)

829

120

Non-GAAP net income (loss)

7,143

(57,250)

(8,301)

Net loss attributable to Yatsen's shareholders

(5,303)

(60,514)

(8,773)

Share-based compensation expenses

8,626

3,559

515

Amortization of intangible assets resulting from assets and business
acquisitions

10,179

10,473

1,518

Revaluation of investments on the share of equity method
investments

(6,010)

(10,469)

(1,518)

Tax effects on non-GAAP adjustments

(405)

829

120

Non-GAAP net income (loss) attributable to Yatsen's
shareholders

7,087

(56,122)

(8,138)

Shares used in calculating loss per share:

Weighted average number of Class A and Class B ordinary shares:

Basic

1,837,466,068

1,876,901,662

1,876,901,662

Diluted

1,953,491,427

1,876,901,662

1,876,901,662

Non-GAAP net income (loss) attributable to ordinary
shareholders per Class A and Class B ordinary share

Basic

0.00

(0.03)

(0.00)

Diluted

0.00

(0.03)

(0.00)

Non-GAAP net income (loss) attributable to ordinary
shareholders per ADS (20 ordinary shares equal to 1 ADS) (1)

Basic

0.08

(0.60)

(0.09)

Diluted

0.07

(0.60)

(0.09)

View original content:https://www.prnewswire.com/news-releases/yatsen-announces-first-quarter-2026-financial-results-302781575.html

SOURCE Yatsen Holding Limited
2026-06-12 19:39 1mo ago
2026-05-26 10:37 2mo ago
Yatsen Holding Limited (YSG) Q1 2026 Earnings Call Transcript
YSG Yatsen Holding
FMP Stock News
Original source text
Yatsen Holding Limited (YSG) Q1 2026 Earnings Call Transcript
2026-06-12 19:39 1mo ago
2026-03-12 01:49 4mo ago
JOYY: A 'Buy' On Above-Expectations Results And Guidance
YY JOYY
FMP Stock News
Original source text
I have retained a "Buy" rating for JOYY, following my assessment of its performance and prospects. JOYY's advertising revenue surged 62% YoY, offsetting legacy live-streaming headwinds in 4Q2025. This was the main reason for its 2.8% group-level top line beat during the same period. Management guides for a 9.8% YoY Q1 2026 top line increase, which should be driven by the ongoing non-livestreaming segment diversification.
2026-06-12 19:39 1mo ago
2026-04-28 09:29 3mo ago
JOYY Inc. Filed 2025 Annual Report on Form 20-F
YY JOYY
FMP Stock News
Original source text
April 28, 2026 09:29 ET  | Source: JOYY Inc.

SINGAPORE, April 28, 2026 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission on April 28, 2026, Eastern Time. The annual report can be accessed on the Company’s investor relations website at http://ir.joyy.com.

The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s Investor Relations Department at [email protected].

About JOYY Inc.

JOYY (NASDAQ: JOYY) is a leading global technology company with a mission to enrich lives through technology. With a diversified product portfolio spanning live streaming, short-form videos, instant messaging, and emerging initiatives such as advertising and smart commerce SaaS, JOYY has transformed into a dynamic ecosystem powered by AI and data intelligence. Headquartered in Singapore and operating across the globe, JOYY empowers creators, merchants and enterprises worldwide. JOYY’s ADSs have been listed on the NASDAQ since November 2012.

Investor Relations Contact

JOYY Inc.
Investor Relations
Email: [email protected]
2026-06-12 19:39 1mo ago
2026-05-15 07:30 2mo ago
JOYY to Announce First Quarter 2026 Financial Results on May 25, 2026
YY JOYY
FMP Stock News
Original source text
May 15, 2026 07:30 ET  | Source: JOYY Inc.

SINGAPORE, May 15, 2026 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced that it plans to release its first quarter 2026 financial results after the U.S. market closes on May 25, 2026.

The Company’s management will host an earnings conference call at 9:00 PM U.S. Eastern Time on Monday, May 25, 2026 (9:00 AM Singapore/Hong Kong Time on Tuesday, May 26, 2026). Details for the conference call are as follows:

Event Title:JOYY Inc. First Quarter 2026 Earnings Conference CallConference ID:#10054918   All participants may use the link provided below to complete the online registration process in advance of the conference call. Upon registration, each participant will receive a set of participant dial-in numbers, the Direct Event passcode, and a unique PIN by email.

PRE-REGISTER LINK: https://s1.c-conf.com/diamondpass/10054918-5w84it.html

A live and archived webcast of the conference call will also be available at the Company's investor relations website at https://ir.joyy.com.

The replay will be accessible through June 2, 2026, by dialing the following numbers:

United States:1-855-883-1031Singapore:
Hong Kong:800-101-3223
800-930-639Conference ID:#10054918   About JOYY Inc.
JOYY (NASDAQ: JOYY) is a leading global technology company, dedicated to building a self-reinforcing ecosystem that integrates social entertainment, programmatic advertising, and omnichannel e-commerce infrastructure, powered by AI and data intelligence. Headquartered in Singapore and operating across the globe, JOYY empowers creators, merchants and enterprises worldwide. JOYY’s ADSs have been listed on the NASDAQ since November 2012.

Investor Relations Contact
JOYY Inc.
Investor Relations
Email: [email protected]
2026-06-12 19:39 1mo ago
2026-05-25 19:00 2mo ago
JOYY Reports First Quarter 2026 Unaudited Financial Results
YY JOYY
FMP Stock News
Original source text
SINGAPORE, May 26, 2026 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced its unaudited financial results for the first quarter of 2026.

First Quarter 2026 Financial Highlights1

Net revenues were US$555.7 million, an increase of 12.4% from US$494.4 million in the corresponding period of 2025, compared with US$581.9 million in the fourth quarter of 2025. Social Entertainment net revenues increased by 3.2% to US$400.4 million from US$387.8 million in the corresponding period of 2025, compared with US$419.1 million in the fourth quarter of 2025.BIGO Ads net revenues increased by 55.6% to US$124.8 million from US$80.2 million in the corresponding period of 2025, compared with US$128.6 million in the fourth quarter of 2025.Shopline net revenues increased by 16.1% to US$30.5 million from US$26.3 million in the corresponding period of 2025, compared with US$34.3 million in the fourth quarter of 2025.
Operating income was US$6.8 million, compared with US$12.2 million in the corresponding period of 2025 and US$18.3 million in the fourth quarter of 2025.
Non-GAAP EBITDA2 was US$45.7 million, compared with US$40.4 million in the corresponding period of 2025 and US$50.6 million in the fourth quarter of 2025.
Net income from continuing operations attributable to controlling interest of JOYY3 was US$50.7 million, compared with US$45.4 million in the corresponding period of 2025 and US$54.3 million in the fourth quarter of 2025.
Non-GAAP net income from continuing operations attributable to controlling interest and common shareholders of JOYY4 was US$55.9 million, compared with US$63.2 million in the corresponding period of 2025 and US$70.3 million in the fourth quarter of 2025.
Net Cash5 as of March 31, 2026 was US$3,175.1 million.
Net Cash from operating activities was US$46.0 million, compared with US$58.0 million in the corresponding period of 2025.

First Quarter 2026 Business Highlights

Global community:

Global average mobile MAUs6 reached 276.3 million in the first quarter of 2026, up by 6.1% from 260.4 million in the corresponding period of 2025 and up by 1.5% from 272.1 million in the fourth quarter of 2025. The Company continued to optimize its marketing strategies to focus on return on investment (ROI) and high-value users. Social Entertainment :

In the first quarter, Social Entertainment revenues increased by 3.2% year over year to US$400.4 million, with live streaming revenues reaching US$380.3 million, returning to year over year growth with a 2.4% increase from the corresponding period of 2025, representing an important inflection point in the recovery of the Company’s core business. By region, live streaming revenues in developed markets grew 11.2% year over year, reflecting strong performance in key geographies.Core live streaming paying users 7 rose by 5.9% year over year to 1.54 million, while ARPPU8 reached US$214.1.The Company continued to enhance its content ecosystem through streamer incentive reforms and targeted support programs for high-quality content categories, while deepening AI-powered capabilities across content distribution and payment experiences. These initiatives drove steady improvements in user engagement and monetization. During the first quarter, the number of active streamers increased by 1.5% quarter over quarter, and average effective streaming hours per streamer rose by 1.4% quarter over quarter. AI-powered tools were fully deployed across core regions. User adoption of AI-generated virtual gifts continued to accelerate, with AI-generated interactive virtual gifts accounting for 34% of total virtual gift consumption on Bigo Live in April 2026. Recent Development on B2B Initiatives: Advertising and Smart Commerce

Beginning in 2022, the Company ramped up efforts to diversify its revenue stream, cultivating its new initiatives in advertising technology and smart commerce. The Company has made steady progress advancing towards its strategic positioning as a global tech company powered by multiple growth engines. In the first quarter, total non-live streaming revenues reached US$175.4 million, up by 42.6% year over year, representing 31.6% of total net revenues of the Company, compared with 24.9% in the corresponding period of 2025. BIGO Ads:

BIGO Ads is a global AI-powered programmatic advertising platform. Launched to provide one-stop marketing and monetization solutions, it leverages deep learning, real-time bidding, and smart bidding models (such as oCPC and ROAS optimization) to enable brands to scale user acquisition and app developers to effectively unlock monetization potentials through connecting premium global demand.In the first quarter, BIGO Ads' total revenues grew by 55.6% year over year to US$124.8 million. In particular, BIGO Audience Network, which includes third-party advertising revenues generated on network partners' traffic properties, continued to demonstrate strong momentum, with revenues increasing by 78.8% year over year.BIGO Ads has access to a vast traffic pool, comprising the Company’s own global average mobile MAU base and an extensive network of third-party traffic through seamless integration of developer traffic across major channels. During the quarter, Software Development Kit (SDK) advertising requests grew by 109% year over year and 7% quarter over quarter.BIGO Ads continued to enhance its deep learning and real-time bidding models. By promoting full-funnel data feedback from advertisers and capitalizing on the dual growth in traffic scale and advertiser density, BIGO Ads built a richer multi-dimensional user profile database. This enabled more precise real-time user understanding, improved ad distribution efficiency, and further strengthened its traffic bidding capabilities through continuous data accumulation and algorithm iteration.Broader traffic coverage, multi-vertical advertiser expansion, and ongoing algorithm optimization fueled accelerated growth. Web-based demand increased 90% year over year. In-app advertising (IAA) spending maintained robust growth of 97% year over year. Regionally, developed markets demonstrated strong momentum, with North America remaining the largest market and Western Europe delivering outstanding growth of 27% quarter over quarter. Shopline:

Shopline serves as a global AI-powered operating system for modern retail. Beyond storefront creation, Shopline offers a deeply integrated suite of merchant services across payments, logistics, marketing, and data analytics. It is an open, extensible omnichannel platform that enables merchants to manage the full commerce value chain from store setup and transactions to fulfillment, customer acquisition, and lifecycle engagement. Shopline has helped merchants in diverse industries across multiple markets to launch and scale their businesses.Shopline currently generates revenues from recurring software subscription fees and a suite of transaction-based value-added services, including localized payment processing (Shopline Payments) and marketing solutions.In the first quarter, Shopline continued its healthy growth trajectory, generating revenue of US$30.5 million, up 16.1% year over year. Gross margin improved to 51.5%. Ms. Ting Li, Chairperson and Chief Executive Officer of JOYY, commented, "We are pleased to report a strong start to 2026. Total revenues for the first quarter reached US$555.7 million, up by 12.4% year over year, our strongest year over year growth rate in recent years. Our social entertainment business returned to year over year growth, while our second growth curve, Ad Tech and Smart Commerce, continued to progress with strong momentum. In light of our solid operational performance and robust balance sheet, we announced an updated shareholder return program, under which we could repurchase up to US$600 million worth of our shares and distribute approximately US$900 million in dividends over the next three years. This underscores our strong confidence in long-term potential of our business and demonstrates our continued commitment to delivering sustainable value to our shareholders.

Social entertainment revenues increased 3.2% year over year, with core live streaming revenues returning to 2.4% year over year growth, which marks an inflection point and a result of the strategic adjustments we’ve executed over the past several quarters. Meanwhile, BIGO Ads revenues surged 55.6% year over year to US$124.8 million, with BIGO Audience Network revenues growing 78.8% year over year. Shopline also continued its healthy growth trajectory, generating revenue of US$30.5 million, up 16.1% year over year.

This quarter marks the first time we are reporting results under our new three-segment structure: Social Entertainment, BIGO Ads, and Shopline. Our globally diversified ecosystem is taking shape, with social entertainment, advertising, and smart commerce reinforcing one another in a powerful strategic flywheel.

With AI serving as the backbone of our entire ecosystem — driving content recommendation, advertising efficiency, and merchant intelligence across all three segments — our business pillars form a closed-loop system that deepens our competitive moat. We are confident this will drive long-term value creation for JOYY and our shareholders."

First Quarter 2026 Financial Results

NET REVENUES

Net revenues were US$555.7 million, representing an increase of 12.4% from US$494.4 million in the corresponding period of 2025, compared with US$581.9 million in the fourth quarter of 2025.

Social Entertainment net revenues were US$400.4 million, up by 3.2% from US$387.8 million in the corresponding period of 2025, compared with US$419.1 million in the fourth quarter of 2025. The year over year increase was primarily driven by growth in live streaming revenues, as expanded content categories and enhanced localized operations contributed to stronger user engagement and spending across key markets.

BIGO Ads net revenues were US$124.8 million, up by 55.6% from US$80.2 million in the corresponding period of 2025, compared with US$128.6 million in the fourth quarter of 2025. The year over year increase was driven by expansion of traffic, elevated advertiser demand across regions and verticals, and enhanced algorithm performance that resulted in improved advertisement delivery efficiency and higher advertiser spending.

Shopline net revenues were US$30.5 million, representing an increase of 16.1% from US$26.3 million in the corresponding period of 2025, compared with US$34.3 million in the fourth quarter of 2025. The year over year growth was mainly due to continued merchant adoption and deeper penetration of value-added services.

COST OF REVENUES AND GROSS PROFIT

Cost of revenues was US$366.4 million in the first quarter of 2026, compared with US$315.7 million in the corresponding period of 2025 and US$376.3 million in the fourth quarter of 2025.

Social Entertainment’s cost of revenues increased by 3.4% year over year to US$256.0 million and decreased by 1.6% from US$260.2 million in the fourth quarter of 2025. The year over year increase was primarily attributable to a US$15.5 million increase in revenue-sharing fees and content costs.

BIGO Ads’s cost of revenues increased by 78.1% year over year to US$95.6 million and decreased 2.6% from US$98.1 million in the fourth quarter of 2025. The year over year increase was primarily resulting from higher traffic acquisition costs paid to third-party partners in relation to the expansion of BIGO Audience Network.

Shopline’s cost of revenues increased by 1.8% year over year to US$14.8 million, and decreased by 17.4% from the fourth quarter of 2025. The quarter over quarter decrease was primarily due to the seasonal decline in revenue from the fourth quarter, as well as continued improvements in cost efficiency.

Gross profit was US$189.3 million in the first quarter of 2026, compared with US$178.6 million in the corresponding period of 2025 and US$205.6 million in the fourth quarter of 2025. Gross margin was 34.1% in the first quarter of 2026, compared with 36.1% in the corresponding period of 2025 and 35.3% in the fourth quarter of 2025.

OPERATING EXPENSES AND INCOME

Operating expenses were US$183.4 million in the first quarter of 2026, compared with US$167.2 million in the same period of 2025 and US$187.8 million in the fourth quarter of 2025. Among the operating expenses, sales and marketing expenses were US$79.6 million, compared with US$72.1 million in the corresponding period of 2025 and US$81.4 million in the fourth quarter of 2025. Research and development expenses were US$61.2 million, compared with US$62.4 million in the corresponding period of 2025 and US$61.5 million in the fourth quarter of 2025. General and administrative expenses were US$42.6 million, compared with US$32.7 million in the corresponding period of 2025 and US$44.9 million in the fourth quarter of 2025.

Operating income was US$6.8 million, compared with US$12.2 million in the corresponding period of 2025 and US$18.3 million in the fourth quarter of 2025.

Non-GAAP operating income9 was US$38.0 million in the first quarter of 2026, compared with US$31.0 million in the corresponding period of 2025 and US$40.8 million in the fourth quarter of 2025. Non-GAAP operating income margin10 was 6.8% in the first quarter of 2026, compared with 6.3% in the corresponding period of 2025 and 7.0% in the fourth quarter of 2025.

Non-GAAP EBITDA was US$45.7 million, compared with US$40.4 million in the corresponding period of 2025 and US$50.6 million in the fourth quarter of 2025. Non-GAAP EBITDA margin11 was 8.2%, compared with 8.2% in the corresponding period of 2025 and 8.7% in the fourth quarter of 2025.

NET INCOME

Net income from continuing operations attributable to controlling interest of JOYY was US$50.7 million, compared with US$45.4 million in the corresponding period of 2025 and US$54.3 million in the fourth quarter of 2025. Net income margin was 9.1% in the first quarter of 2026, compared with 9.2% in the corresponding period of 2025 and 9.3% in the fourth quarter of 2025.

Non-GAAP net income from continuing operations attributable to controlling interest and common shareholders of JOYY was US$55.9 million, compared with US$63.2 million in the corresponding period of 2025 and US$70.3 million in the fourth quarter of 2025. Non-GAAP net income margin12 was 10.1% in the first quarter of 2026, compared with non-GAAP net income margin of 12.8% in the corresponding period of 2025 and 12.1% in the fourth quarter of 2025.

NET INCOME PER ADS

Diluted net income from continuing operations per ADS13 was US$1.00 in the first quarter of 2026, compared with US$0.84 in the corresponding period of 2025 and US$1.03 in the fourth quarter of 2025.

Non-GAAP diluted net income from continuing operations per ADS14 was US$1.11 in the first quarter of 2026, compared with US$1.18 in the corresponding period of 2025 and US$1.34 in the fourth quarter of 2025.

BALANCE SHEET AND CASH FLOWS

As of March 31, 2026, the Company had net cash of US$3,175.1 million, compared with US$3,258.0 million as of December 31, 2025. For the first quarter of 2026, net cash from operating activities was US$46.0 million.

SHARES OUTSTANDING

As of March 31, 2026, the Company had a total of 1,007.6 million common shares outstanding, representing the equivalent of 50.4 million ADSs assuming the conversion of all common shares into ADSs.

Business Outlook

For the second quarter of 2026, the Company expects net revenues to be between US$562 million and US$581 million. This forecast reflects the Company’s current and preliminary views on the market, operational conditions and business strategies, which are subject to changes, particularly as to the potential impact from macroeconomic uncertainties.

Share Repurchase Programs

On May 22, 2026, the board of directors of the Company authorized a new share repurchase program, or the 2026 Repurchase Program, under which the Company is authorized to repurchase up to US$600 million of its shares (including in the form of ADSs) until the end of 2028. The 2026 Repurchase Program is effective immediately upon approval and replaces a pre-existing share repurchase program, or the 2025 Repurchase Program, under which the Company was authorized to repurchase up to US$300 million of its shares (including in the form of ADSs) until the end of 2027.

Pursuant to the 2025 Repurchase Program, the Company had repurchased approximately 0.8 million ADSs for an aggregate consideration of US$52.9 million on the open market during the first quarter of 2026. Between March 31, 2026 and May 22, 2026, the Company repurchased an additional approximately 0.6 million ADSs, for an aggregate consideration of US$35.0 million.

As of the date of this announcement, the remaining unutilized amount under the 2026 Repurchase Program was approximately US$600 million.

Quarterly Dividend Program and Additional Cash Dividend

On May 22, 2026, the board of directors of the Company authorized a new quarterly dividend program, or the 2026 Dividend Program, under which a total of approximately US$900 million in cash will be distributed on a quarterly basis between 2026 and 2028. The 2026 Dividend Program is effective immediately upon approval and replaces a pre-existing quarterly dividend program, or the 2025 Dividend Program, under which a total of approximately US$600 million in cash would be distributed on a quarterly basis between 2025 and 2027.

Pursuant to the 2026 Dividend Program, the board of directors has accordingly declared a dividend of US$1.50 per ADS, or US$0.075 per common share, for the first quarter of 2026, which is expected to be paid on July 14, 2026 to shareholders of record as of the close of business on June 29, 2026. The ex-dividend date will be June 29, 2026.

Conference Call Information

The Company will hold a conference call at 9:00 PM U.S. Eastern Time Monday, May 25, 2026 (9:00 AM Singapore/Hong Kong Time on Tuesday, May 26, 2026) Details for the conference call are as follows:

Event Title:JOYY Inc. First Quarter 2026 Earnings Conference CallConference ID:#10054918   All participants may use the link provided below to complete the online registration process in advance of the conference call. Upon registration, each participant will receive a set of participant dial-in numbers, the Direct Event passcode, and a unique PIN by email.

PRE-REGISTER LINK: https://s1.c-conf.com/diamondpass/10054918-5w84it.html

A live and archived webcast of the conference call will also be available at the Company's investor relations website at https://ir.joyy.com.

The replay will be accessible through June 2, 2026, by dialing the following numbers:

United States:1-855-883-1031Singapore:
Hong Kong:800-101-3223
800-930-639Conference ID:#10054918   About JOYY Inc.

JOYY (NASDAQ: JOYY) is a leading global technology company, dedicated to building a self-reinforcing ecosystem that integrates social entertainment, programmatic advertising, and omnichannel e-commerce infrastructure, powered by AI and data intelligence. Headquartered in Singapore and operating across the globe, JOYY empowers creators, merchants and enterprises worldwide. JOYY’s ADSs have been listed on the NASDAQ since November 2012.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the business outlook and quotations from management in this press release, as well as JOYY’s strategic and operational plans, contain forward-looking statements. JOYY may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (“SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about JOYY’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: JOYY’s goals and strategies; JOYY’s future business development, results of operations and financial condition; the expected growth of the global online social entertainment, advertising and smart commerce market; JOYY’s ability to attract and retain users and customers; JOYY’s expectations regarding demand for and market acceptances of its products and services; JOYY’s ability to adopt the latest technology to enhance its operations; fluctuations in global economic and business conditions; and assumptions underlying or related to any of the foregoing. A more detailed and full discussion of those risks and other potential risks is included in JOYY’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and JOYY does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Use of Non-GAAP Financial Measures

The unaudited condensed consolidated financial information is prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). JOYY uses non-GAAP operating (loss) income, non-GAAP operating income (loss) margin, non-GAAP EBITDA, non-GAAP EBITDA margin, non-GAAP net income (loss) from continuing operations attributable to controlling interest and common shareholders of JOYY, non-GAAP net income (loss) margin attributable to controlling interest and common shareholders of JOYY, and basic and diluted non-GAAP net income (loss) from continuing operations per ADS, all of which are non-GAAP financial measures adjusted from the most comparable U.S. GAAP results. Non-GAAP operating income (loss) is operating income (loss) excluding share-based compensation expenses, impairment of goodwill and investments, amortization of intangible assets from business acquisitions, and gain (loss) on deconsolidation and disposal of subsidiaries and business. Non-GAAP operating income (loss) margin is non-GAAP operating income as a percentage of net revenues. Non-GAAP net income (loss) from continuing operations is net income (loss) from continuing operations excluding share-based compensation expenses, impairment of goodwill and investments, amortization of intangible assets from business acquisitions, gain (loss) on deconsolidation and disposal of subsidiaries and business, gain (loss) on disposal and deemed disposal of investments, gain (loss) on fair value change of investments, reconciling items on the share of equity method investments (referring to share of income (loss) from equity method investments resulting from non-recurring or non-cash items of the equity method investments), interest expenses related to the convertible bonds’ amortization to face value, and income tax effects of the above non-GAAP reconciling items. Non-GAAP EBITDA is non-GAAP operating income (loss) added back depreciation and amortization (other than amortization of intangible assets resulting from assets and business acquisitions), and non-GAAP EBITDA margin is non-GAAP EBITDA as a percentage of net revenues. Non-GAAP net income (loss) from continuing operations attributable to controlling interest and common shareholders of JOYY is net income (loss) from continuing operations attributable to controlling interest of JOYY excluding share-based compensation expenses, impairment of goodwill and investments, amortization of intangible assets from business acquisitions, gain (loss) on deconsolidation and disposal of subsidiaries and business, gain (loss) on disposal and deemed disposal of investments, gain (loss) on fair value change of investments, reconciling items on the share of equity method investments, interest expenses related to the convertible bonds’ amortization to face value, income tax effects of the above non-GAAP reconciling items and adjustments for non-GAAP reconciling items for the net income (loss) from continuing operations attributable to non-controlling interest shareholders. Non-GAAP net income (loss) margin is non-GAAP net income (loss) from continuing operations attributable to controlling interest and common shareholders of JOYY as a percentage of net revenues. Non-GAAP net income (loss) from continuing operations attributable to controlling interest and common shareholders of JOYY is net income (loss) from continuing operations attributable to common shareholders of JOYY excluding share-based compensation expenses, impairment of goodwill and investments, amortization of intangible assets from business acquisitions, gain (loss) on deconsolidation and disposal of subsidiaries and business, gain (loss) on disposal and deemed disposal of investments, gain (loss) on fair value change of investments, reconciling items on the share of equity method investments, interest expenses related to the convertible bonds’ amortization to face value, accretion, cumulative dividend and deemed dividend to subsidiaries’ preferred shareholders, gain on repurchase of redeemable convertible preferred shares of a subsidiary and income tax effects of above non-GAAP reconciling items and adjustments for non-GAAP reconciling items for the net income (loss) from continuing operations attributable to non-controlling interest shareholders. Basic and diluted non-GAAP net income (loss) from continuing operations per ADS is non-GAAP net income (loss) from continuing operations attributable to common shareholders of JOYY divided by weighted average number of ADS used in the calculation of basic and diluted net income (loss) per ADS. The Company believes that separate analysis and exclusion of the non-cash impact of above reconciling items adds clarity to the constituent parts of its performance. The Company reviews these non-GAAP financial measures together with GAAP financial measures to obtain a better understanding of its operating performance. It uses the non-GAAP financial measures for planning, forecasting and measuring results against the forecast. The Company believes that non-GAAP financial measures is useful supplemental information for investors and analysts to assess its operating performance without the non-cash effect of (i) share-based compensation expenses, amortization of intangible assets from business acquisitions, and interest expenses related to the convertible bonds’ amortization to face value, which have been and will continue to be significant recurring expenses in its business, (ii) impairment of goodwill and investments, gain (loss) on deconsolidation and disposal of subsidiaries and business, gain (loss) on disposal and deemed disposal of investments, gain (loss) on fair value change of investments, reconciling items on the share of equity method investments, accretion, cumulative dividend and deemed dividend to subsidiaries’ preferred shareholders and gain on repurchase of redeemable convertible preferred shares of a subsidiary which may not be recurring in its business, and (iii) income tax expenses and non-GAAP adjustments for net income (loss) from continuing operations attributable to non-controlling interest shareholders, which are affected by the above non-GAAP reconciling items. However, the use of non-GAAP financial measures has material limitations as an analytical tool. One of the limitations of using non-GAAP financial measures is that they do not include all items that impact the Company’s net income (loss) for the period. In addition, because non-GAAP financial measures are not measured in the same manner by all companies, they may not be comparable to other similar titled measures used by other companies. In light of the foregoing limitations, you should not consider non-GAAP financial measures in isolation from or as an alternative to the financial measures prepared in accordance with U.S. GAAP.

The presentation of these non-GAAP financial measures is not intended to be considered in isolation from, or as a substitute for, the financial information prepared and presented in accordance with U.S. GAAP. For more information on these non-GAAP financial measures, please see the table captioned “JOYY Inc. Unaudited Reconciliation of GAAP and Non-GAAP Results” near the end of this press release.

Investor Relations Contact

JOYY Inc.
Investor Relations
Email: [email protected]

1 The financial information and non-GAAP financial information disclosed in this press release is presented on a continuing operations basis, unless otherwise specifically stated. Starting from the first quarter of 2026, the Company reports three segments, Social Entertainment, BIGO Ads and Shopline, to reflect changes made to the reporting structure whose financial information is reviewed by the chief operating decision makers of the Company under its evolving operating strategies. Social Entertainment mainly includes live streaming services on our social entertainment platforms including but not limited to Bigo Live, Likee, imo, and others. BIGO Ads mainly engages in advertising services on the Company's own properties (specifically Likee and imo) and third-party network partners’ properties. Shopline mainly engages in providing omnichannel smart commerce solutions for merchants. Prior period segment information has been recast to conform to the current period's presentation.

2 Non-GAAP EBITDA is a non-GAAP financial measure, which is defined as non-GAAP operating income (loss) added back depreciation and amortization (other than amortization of intangible assets resulting from assets and business acquisitions). Please refer to the section titled “Use of Non-GAAP Financial Measures” and the table captioned “JOYY Inc. Unaudited Reconciliation of GAAP and Non-GAAP Results” near the end of this press release for details.

3 Net income (loss) from continuing operations attributable to controlling interest of JOYY is net income (loss) from continuing operations less net (loss) income from continuing operations attributable to the non-controlling interest shareholders and the mezzanine equity classified non-controlling interest shareholders.

4 Non-GAAP net income (loss) from continuing operations attributable to controlling interest and common shareholders of JOYY is a non-GAAP financial measure, which is defined as net income (loss) from continuing operations attributable to common shareholders of JOYY excluding share-based compensation expenses, impairment of goodwill and investments, amortization of intangible assets from business acquisitions, gain (loss) on deconsolidation and disposal of subsidiaries and business, gain (loss) on disposal and deemed disposal of investments, gain (loss) on fair value change of investments, reconciling items on the share of equity method investments which refer to those similar non-GAAP reconciling items of the Company, interest expenses related to the convertible bonds amortization to face value, accretion, cumulative dividend and deemed dividend to subsidiaries’ preferred shareholders, income tax effects of the above non-GAAP reconciling items and adjustments for non-GAAP reconciling items for net (loss) income attributable to non-controlling interest shareholders. Please refer to the section titled “Use of Non-GAAP Financial Measures” and the table captioned “JOYY Inc. Unaudited Reconciliation of GAAP and Non-GAAP Results” near the end of this press release for details.

5 Net cash is calculated as the sum of cash and cash equivalents, restricted cash and cash equivalents, short-term deposits, restricted short-term deposits, short-term investments, long-term deposits and held-to-maturity investments, less short-term and long-term loans.

6 Refers to average mobile monthly active users of the social entertainment platforms operated by the Company, including Bigo Live, Likee, imo and Hago. Average mobile MAU for any period is calculated by dividing (i) the sum of the Company’s active mobile users for each month of such period, by (ii) the number of months in such period.

7 Core live streaming paying users during a given period is calculated as the cumulative number of registered user accounts that have purchased virtual items or other products and services on Bigo Live, Likee or imo at least once during the relevant period.

8 Average revenue per user is calculated by dividing the Company’s total revenues from live streaming on Bigo Live, Likee and imo during a given period by the number of paying users for the Company’s live streaming services on these platforms for that period.

9 Non-GAAP operating income (loss) is a non-GAAP financial measure, which is defined as operating income (loss) excluding share-based compensation expenses, amortization of intangible assets from business acquisitions, impairment of goodwill and investments and gain (loss) on deconsolidation and disposal of subsidiaries and business. Please refer to the section titled “Use of Non-GAAP Financial Measures” and the table captioned “JOYY Inc. Unaudited Reconciliation of GAAP and Non-GAAP Results” near the end of this press release for details.

10 Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP operating income (loss) as a percentage of net revenues. Please refer to the section titled “Use of Non-GAAP Financial Measures” and the table captioned “JOYY Inc. Unaudited Reconciliation of GAAP and Non-GAAP Results” near the end of this press release for details.

11 Non-GAAP EBITDA margin is a non-GAAP financial measure, which is defined as non-GAAP EBITDA as a percentage of net revenues. Please refer to the section titled “Use of Non-GAAP Financial Measures” and the table captioned “JOYY Inc. Unaudited Reconciliation of GAAP and Non-GAAP Results” near the end of this press release for details.

12 Non-GAAP net income (loss) margin is non-GAAP net income from continuing operations attributable to controlling interest and common shareholders of JOYY as a percentage of net revenues.

13 ADS refers to American Depositary Share. Each ADS represents twenty Class A common shares of the Company. Diluted net income (loss) per ADS is net income (loss) attributable to common shareholders of JOYY divided by weighted average number of diluted ADS.

14 Non-GAAP diluted net income (loss) from continuing operations per ADS is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from continuing operations attributable to common shareholders of JOYY divided by weighted average number of ADS used in the calculation of diluted net income (loss) per ADS. Please refer to the section titled “Use of Non-GAAP Financial Measures” and the table captioned “JOYY Inc. Unaudited Reconciliation of GAAP and Non-GAAP Results” near the end of this press release for details.

JOYY INC.UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS(All amounts in thousands, except share, ADS and per ADS data)       December 31, March 31,  2025 2026  US$ US$Assets   Current assets    Cash and cash equivalents374,248 309,167 Restricted cash and cash equivalents21,593 21,107 Short-term deposits192,535 154,460 Restricted short-term deposits7,182 4,386 Short-term investments613,702 657,238 Accounts receivable, net154,439 161,363 Amounts due from related parties106 190 Prepayments and other current assets255,566 290,375     Total current assets1,619,371 1,598,286     Non-current assets    Long-term deposits and held-to-maturity investments2,059,386 2,052,055 Deferred tax assets9,782 10,920 Investments551,802 589,087 Property and equipment, net565,124 587,978 Land use rights, net301,390 303,951 Intangible assets, net221,963 208,236 Right-of-use assets, net21,241 28,124 Goodwill2,194,358 2,194,382 Other non-current assets8,071 6,104     Total non-current assets5,933,117 5,980,837     Total assets7,552,488 7,579,123          Liabilities, mezzanine equity and shareholders’ equity   Current liabilities    Short-term loans10,672 23,299 Accounts payable71,551 68,201 Deferred revenue61,713 59,258 Advances from customers5,408 6,293 Income taxes payable64,533 69,101 Accrued liabilities and other current liabilities626,678 636,855 Amounts due to related parties24,472 33,253 Lease liabilities due within one year8,939 10,658     Total current liabilities873,966 906,918     Non-current liabilities    Lease liabilities12,029 17,478 Deferred revenue9,522 9,136 Deferred tax liabilities54,941 61,304 Other non-current liabilities- 392     Total non-current liabilities76,492 88,310     Total liabilities950,458 995,228      JOYY INC.UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)(All amounts in thousands, except share, ADS and per ADS data)       December 31, March 31,  2025
 2026
  US$ US$     Mezzanine equity25,333  25,733      Shareholders’ equity    Class A common shares (US$0.00001 par value; 10,000,000,000 and 10,000,000,000 shares authorized, 1,306,734,444 shares issued and 673,183,174 shares outstanding as of December 31, 2025; 1,206,734,444 shares issued and 681,126,029 shares outstanding as of March 31, 2026, respectively)7  7  Class B common shares (US$0.00001 par value; 1,000,000,000 and 1,000,000,000 shares authorized, 326,509,555 and 326,509,555 shares issued and outstanding as of December 31, 2025 and March 31, 2026, respectively)3  3  Treasury shares (US$0.00001 par value; 633,551,270 and 525,608,415 shares held as of December 31, 2025 and March 31, 2026, respectively)(1,302,098) (1,095,211) Additional paid-in capital3,315,070  3,072,485  Statutory reserves37,869  37,869  Retained earnings4,699,089  4,680,560  Accumulated other comprehensive loss(208,093) (168,409)     Total JOYY Inc.’s shareholders’ equity6,541,847  6,527,304      Non-controlling interests34,850  30,858      Total shareholders’ equity6,576,697  6,558,162      Total liabilities, mezzanine equity and shareholders’ equity7,552,488  7,579,123       JOYY INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(All amounts in thousands, except share, ADS and per ADS data)       Three Months Ended March 31, December 31, March 31, 2025
 2025
 2026
 US$ US$ US$Net revenues(1)     Live streaming371,348  394,436  380,265 Advertising88,647  145,430  137,204 Others34,356  42,050  38,231       Total net revenues494,351  581,916  555,700       Cost of revenues(2)(315,736) (376,275) (366,403)      Gross profit178,615  205,641  189,297       Operating expenses(2)     Research and development expenses(62,426) (61,538) (61,187)Sales and marketing expenses(72,131) (81,415) (79,649)General and administrative expenses(32,690) (44,867) (42,572)      Total operating expenses(167,247) (187,820) (183,408)      Loss on deconsolidation and disposal of subsidiaries-
  -
  (245)Other income839  444  1,189       Operating income12,207  18,265  6,833       Interest expenses(106) (162) (38)Interest income and investment income39,387  40,873  39,765 Foreign currency exchange losses, net(761) (8,171) (13,555)Gain (loss) on fair value change of investments705  (10,120) (7,958)      Income before income tax expenses51,432  40,685  25,047       Income tax expenses(5,211) (1,368) (4,834)      Income before share of (loss) income in equity method investments, net of income taxes46,221  39,317  20,213       Share of (loss) income in equity method investments, net of income taxes(3,318) 11,868  27,953       Net income from continuing operations42,903  51,185  48,166       Gain on disposal of YY Live(3)1,875,921  -
  -
       Net income1,918,824  51,185  48,166       Net loss attributable to the non-controlling interest shareholders and the mezzanine equity classified non-controlling interest shareholders2,499  3,142  2,501       Net income attributable to controlling interest of JOYY Inc.1,921,323  54,327  50,667       Including:     Net income from continuing operations attributable to controlling interest of JOYY Inc.
45,402  54,327  50,667 Gain on disposal of YY Live(3)1,875,921  -
  -
       Accretion of subsidiaries’ redeemable convertible preferred shares to redemption value(347) (346) (346)      Net income attributable to common shareholders of JOYY Inc.1,920,976  53,981  50,321       Including:     Net income from continuing operations attributable to common shareholders of JOYY Inc.45,055  53,981  50,321 Gain on disposal of YY Live(3)1,875,921  -
  -
        JOYY INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (CONTINUED)(All amounts in thousands, except share, ADS and per ADS data)       Three Months Ended March 31, December 31, March 31, 2025 2025 2026 US$ US$ US$      Net income per ADS     —Basic36.09 1.04 1.01Continuing operations0.85 1.04 1.01Discontinued operations35.24 - -—Diluted35.72 1.03 1.00Continuing operations0.84 1.03 1.00Discontinued operations34.88 - -      Weighted average number of ADS used in calculating net income per ADS     —Basic53,237,127 51,794,999 49,767,292—Diluted53,780,111 52,629,562 50,534,120            (1) Net revenues by geographical areas were as follows:       Three Months Ended March 31, December 31, March 31, 2025 2025 2026 US$ US$ US$      Developed countries and regions277,615 356,624 343,244Middle East66,651 58,899 58,760Mainland China48,385 59,817 52,063Southeast Asia and others101,700 106,576 101,633      Note: Developed countries and region mainly included the United States of America, Singapore, Japan, South Korea and Great Britain. Middle East mainly included Saudi Arabia and other countries located in the region. Southeast Asia and others mainly included Indonesia, Vietnam and rest of the world.      (2) Share-based compensation was allocated in cost of revenues and operating expenses as follows:       Three Months Ended March 31, December 31, March 31, 2025 2025 2026 US$ US$ US$      Cost of revenues635 1,199 802Research and development expenses2,138 3,231 1,480Sales and marketing expenses229 573 422General and administrative expenses2,235 4,035 14,633      (3) Gain from disposal of YY Live amounted to approximately US$ 1.9 billion, which was reported as part of the net income from discontinued operations in the first quarter of 2025.       JOYY INC.UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS(All amounts in thousands, except share, ADS and per ADS data)       Three Months Ended March 31, December 31, March 31, 2025
 2025
 2026
 US$ US$ US$      Operating income12,207  18,265  6,833 Share-based compensation expenses5,237  9,038  17,337 Amortization of intangible assets from business acquisitions13,540  13,540  13,540 Loss on deconsolidation and disposal of subsidiaries-
  -
  245 Non-GAAP operating income30,984  40,843  37,955 Depreciation and other amortization9,402  9,774  7,781 Non-GAAP EBITDA40,386  50,617  45,736             Net income from continuing operations42,903  51,185  48,166 Share-based compensation expenses5,237  9,038  17,337 Amortization of intangible assets from business acquisitions13,540  13,540  13,540 Loss on deconsolidation and disposal of subsidiaries-
  -
  245 (Gain) loss on fair value change of investments(705) 10,120  7,958 Income tax effects on non-GAAP adjustments(1,404) (2,550) (3,012)Reconciling items on the share of equity method investments1,887  (13,483) (30,192)Non-GAAP net income from continuing operations61,458  67,850  54,042             Net income from continuing operations attributable to common shareholders of JOYY Inc.45,055  53,981  50,321 Share-based compensation expenses5,237  9,038  17,337 Amortization of intangible assets from business acquisitions13,540  13,540  13,540 Loss on deconsolidation and disposal of subsidiaries-
  -
  245 (Gain) loss on fair value change of investments(705) 10,120  7,958 Accretion, cumulative dividend and deemed dividend to subsidiaries’ preferred shareholders347  346  346 Income tax effects on non-GAAP adjustments(1,404) (2,550) (3,012)Reconciling items on the share of equity method investments1,887  (13,483) (30,192)Non-GAAP adjustments for net loss attributable to the non-controlling interest shareholders(761) (722) (602)Non-GAAP net income from continuing operations attributable to controlling interest and common shareholders of JOYY Inc.63,196  70,270  55,941                   Non-GAAP net income from continuing operations per ADS     —Basic1.19  1.36  1.12 —Diluted1.18  1.34  1.11       Weighted average number of ADS used in calculating Non-GAAP net income from continuing operations per ADS     —Basic53,237,127  51,794,999  49,767,292 —Diluted53,780,111  52,629,562  50,534,120        JOYY INC.UNAUDITED SEGMENT REPORT(All amounts in thousands, except share, ADS and per ADS data)         Three Months Ended  March 31, December 31, March 31,  2025
 2025
 2026
  US$ US$ US$Net revenues:      Social Entertainment 387,813  419,050  400,367 BIGO Ads 80,220  128,611  124,787 Shopline 26,318  34,255  30,546 Total net revenues 494,351  581,916  555,700        Cost of revenues(1):      Social Entertainment (247,494) (260,186) (255,979)BIGO Ads (53,675) (98,149) (95,600)Shopline (14,567) (17,940) (14,824)Total cost of revenues (315,736) (376,275) (366,403)       Gross profit:      Social Entertainment 140,319  158,864  144,388 BIGO Ads 26,545  30,462  29,187 Shopline 11,751  16,315  15,722 Total gross profit 178,615  205,641  189,297        (1)    Share-based compensation allocated to cost of revenues by segment as follows:         Three Months Ended  March 31, December 31, March 31,  2025
 2025
 2026
  US$ US$ US$       Social Entertainment 597  1,149  826 BIGO Ads 1  23  16 Shopline 37  27  (40)Total share-based compensation allocated to cost of revenues 635  1,199  802 
2026-06-12 19:39 1mo ago
2026-05-25 22:18 2mo ago
JOYY Reports First Quarter 2026 Financial Results: Total Revenue Up 12.4% YoY, Substantially Expanding Shareholder Returns
YY JOYY
FMP Stock News
Original source text
, /PRNewswire/ -- JOYY Inc. (NASDAQ: JOYY) ("JOYY" or the "Company"), a leading global technology company, today announced its unaudited financial results for the first quarter ended March 31, 2026.

In the first quarter, JOYY's globally diversified ecosystem continued to take shape, with its three business pillars—social entertainment, advertising, and e-commerce—bolstering one another in a self-reinforcing strategic flywheel. The Company's total revenues for the quarter grew 12.4% year over year to US$555.7 million, the highest year-over-year growth rate the Company has delivered in recent years. Social entertainment revenue was US$400.4 million, up 3.2% year over year, while the Company's second growth engine, BIGO Ads ad tech and SHOPLINE e-commerce, continued to scale with strong momentum. BIGO Ads contributed US$124.8 million, up 55.6% year over year, while SHOPLINE revenue increased 16.1% year over year to US$30.5 million. In the first quarter, non-GAAP[1] operating income and non-GAAP[1] EBITDA came in at US$38.0 million and US$45.7 million, up 22.5% and 13.2% year over year, respectively. Operating cash inflow for the quarter was US$46.0 million.

Simultaneously, JOYY announced a new share repurchase program, under which the Company is authorized to repurchase up to US$600 million of its shares until the end of 2028, and a new quarterly dividend program, under which a total of approximately US$900 million in cash will be distributed on a quarterly basis between 2026 and 2028. The new shareholder return program, totaling US$1.5 billion, represents a significant increase compared to the previous program (US$900 million)  announced in 2025. From January 1 to May 22, 2026, JOYY had returned a total of US$156.8 million to shareholders through US$87.9 million in share repurchases and US$68.9 million in dividends, under its 2025 program.

Ms. Ting Li, Chairperson and Chief Executive Officer of JOYY, commented, "We delivered a strong start to 2026. Total revenues for the first quarter reached US$555.7 million, up by 12.4% year over year, our strongest year-over-year growth rate in recent years. This quarter marks the first time we are reporting results under our new three-segment structure: Social Entertainment, BIGO Ads, and SHOPLINE. Our AI-driven globally diversified ecosystem is taking shape with social entertainment, advertising, and e-commerce reinforcing one another in a powerful strategic flywheel. With AI serving as the backbone of our entire operations—driving content recommendation, advertising efficiency, and merchant intelligence across all three segments—our business pillars form a closed-loop system that deepens our competitive moat and drives long-term value creation for JOYY and our shareholders."

First Quarter 2026 Financial Highlights

Net revenues in the first quarter of 2026 were US$555.7 million, representing an increase of 12.4% from US$494.4 million in the first quarter of 2025. - Social Entertainment revenue increased by 3.2% to US$400.4 million from US$387.8 million in the first quarter of 2025.

- BIGO Ads revenue increased by 55.6% to US$124.8 million from US$80.2 million in the first quarter of 2025.

- SHOPLINE revenue increased by 16.1% to US$30.5 million from US$26.3 million in the first quarter of 2025.

Operating income was US$6.8 million.
  Non-GAAP[1] operating income was US$38.0 million, representing an increase of 22.5% from US$31.0 million in the first quarter of 2025. Non-GAAP[1] EBITDA was US$45.7 million, representing an increase of 13.2% from US$40.4 million in the first quarter of 2025. Net cash as of March 31, 2026 was US$3,175.1 million. Net cash from operating activities was US$46.0 million. First Quarter 2026 Business Highlights

Social Entertainment Business

In the first quarter, global average mobile MAUs reached 276.3 million, up 6.1% year over year and 1.5% quarter over quarter. Social entertainment revenue increased by 3.2% year over year to US$400.4 million, with livestreaming revenue up 2.4% year over year. Core livestreaming paying users grew 5.9% year over year.

For flagship product Bigo Live, the Company improved its streamer incentive structure, launched targeted support programs for high-quality content categories, and integrated new AI capabilities. These initiatives drove ongoing gains in both content engagement and payment conversion. Number of active streamers increased 1.5% quarter over quarter, and average effective streaming hours per streamer rose 1.4% quarter over quarter. The Company has now fully rolled out AI smart tools for streamers across core markets, meaningfully improving interaction efficiency. In April, AI-generated interactive virtual gifts accounted for 34% of total virtual gift consumption on Bigo Live.

On the operating side, Bigo Live successfully hosted BIGO Awards Gala 2026 in South Korea along with regional galas in countries including Indonesia and the Philippines during the first quarter. These events underscore Bigo Live's continued commitment to recognizing creator excellence, strengthening regional creator ecosystems, and connecting diverse communities worldwide. Bigo Live continued to pursue content innovation and successfully launched the inaugural BIGO Content Award in North America, drawing over 300 top-tier, highly active streamers to drive measurable growth in DAUs and user retention. Additionally, Bigo Live launched a Ramadan-themed initiative featuring a digital revival of traditional content, which drove user engagement during a key cultural period and reinforced its capability to deliver scalable and localized content experiences across diverse markets.

BIGO Ads Advertising Technology Business

In the first quarter, broader traffic coverage, multi-vertical advertiser expansion, and ongoing algorithm optimization fueled the growth momentum of JOYY's ad tech business. BIGO Ads generated US$124.8 million in advertising revenue, up 55.6% year over year, with third-party Audience Network ad revenue delivering 78.8% year-over-year growth.

On the supply side, SDK traffic maintained strong growth, up 109% year over year in the first quarter. On the demand side, the Company's strategic presence across multiple verticals drove an enrichment of its advertiser mix and enhanced ecosystem density. This multi-vertical approach not only accelerated data accumulation and algorithmic iteration, but also strengthened its traffic bidding capabilities. Notably, web-based demand grew 90% year over year and delivered positive sequential growth, while IAA demand sustained 97% year-over-year growth. Geographically, BIGO Ads continued to prioritize high-value developed markets. North America remains its largest market, while Western Europe delivered notable momentum, with revenue up 27% quarter over quarter.

On the algorithm side, BIGO Ads is steadily and prudently scaling its computing infrastructure and strengthening its R&D talent base. By integrating data feedback from advertisers across channels and leveraging the dual growth of traffic scale and advertiser density, BIGO Ads has built a rich behavioral data layer. This enables multi-dimensional, precise user profiling and real-time model iteration, which in turn improves ad delivery efficiency.

SHOPLINE E-Commerce Business

In the first quarter, SHOPLINE delivered strong results. Revenue was US$30.5 million, up 16.1% year over year, with gross margin expanding further to 51.5%. Revenue growth from cross-border merchants remained robust, sustaining over 60% year-over-year growth. This is the first quarter the Company is reporting SHOPLINE as a standalone segment, underscoring the Company's diversified growth.

As global commerce enters the omnichannel era, merchants increasingly desire autonomy and full-funnel data ownership. The Company is building SHOPLINE as an AI-native, one-stop omnichannel commerce infrastructure that offers merchants a fully open and connectable retail operating system. Through deep integration of payment, logistics, and marketing modules, SHOPLINE empowers merchants across every stage of their journey, from store setup and transactions to fulfillment and full-lifecycle customer retention.

SHOPLINE is accelerating the integration of a suite of AI-powered capabilities. These tools will drive SHOPLINE's evolution from an enablement tool to an AI-driven commerce engine. AI-powered traffic allocation and automated decision-making will unlock new growth opportunities and new levels of precision across omnichannel retail.

This press release includes certain non-GAAP financial measures as additional clarifying items to aid investors in further understanding the Company's performance and the impact that these items and events had on the financial results. The non-GAAP financial measures provided above should not be considered as a substitute for, or superior to, the measures of financial performance prepared in accordance with GAAP. For details of the non-GAAP measures, including the reconciliations of GAAP measures to non-GAAP measures, please refer to the press release titled "JOYY Reports First Quarter 2026 Unaudited Financial Results" issued by the Company on May 26, 2026. SOURCE JOYY Inc.
2026-06-12 19:39 1mo ago
2026-05-25 23:03 2mo ago
JOYY Q1 Earnings Call Highlights
YY JOYY
FMP Stock News
Original source text
JOYY NASDAQ: YY reported its strongest year-over-year revenue growth in recent years in the first quarter of 2026, as its social entertainment business returned to growth and newer businesses in advertising technology and commerce continued to scale.

The company said total net revenue rose 12.4% year-over-year to $555.7 million. Non-GAAP operating profit increased 22.5% to $38 million, while non-GAAP EBITDA rose 13.2% to $45.7 million. Operating cash flow was $46 million for the quarter, and JOYY ended March with approximately $3.18 billion in net cash.

The quarter was also the first in which JOYY reported results under a new three-segment structure: Social Entertainment, BIGO Ads and Shopline. Management described the shift as reflecting the growing importance of BIGO Ads and Shopline as scalable growth engines alongside the company’s foundational social entertainment business.

Get JOYY alerts:

Social entertainment returns to growth Social entertainment revenue was $400.4 million in the first quarter, up 3.2% year-over-year. Live streaming revenue increased 2.4% year-over-year, while core live streaming paying users grew 5.9%.

Jane Xie, JOYY’s senior manager of investor relations, reading prepared remarks on behalf of Chairperson and CEO Ting Li, said the company’s global average mobile monthly active users reached 276 million, up 6.1% from a year earlier and 1.5% sequentially. She said traffic from the company’s instant messenger increased 3.1% quarter-over-quarter, supported by user stickiness and organic growth.

Management attributed the recovery in live streaming to improved streamer incentive structures, support for higher-quality content categories and new AI capabilities. Xie said active streamers increased 1.5% sequentially and average effective streaming hours per streamer rose 1.4%, despite typical seasonal pressure in the first quarter.

The company also highlighted the impact of AI tools on engagement. Xie said AI-generated interactive virtual gifts accounted for 34% of total virtual gift consumption on BIGO LIVE as of April. JOYY’s new product lineup also gained traction, with revenue rising more than 500% year-over-year and 45% quarter-over-quarter.

In response to a question from Jefferies analyst Thomas Chong, Ting Li said, through a translator, that structural enhancements launched since the second half of 2024 had strengthened the live streaming ecosystem. She said the company expects low- to mid-single-digit year-over-year growth in social entertainment revenue in the second quarter and believes social entertainment and live streaming revenue can achieve steady positive growth in 2026.

BIGO Ads continues rapid expansion BIGO Ads generated $124.8 million in first-quarter revenue, up 55.6% year-over-year. The company’s third-party advertising business, BIGO Audience Network, grew 78.8% from a year earlier.

Management said growth was driven by broader traffic coverage, advertiser expansion across multiple verticals and algorithm improvements. SDK traffic rose 109% year-over-year and 7% sequentially. Web-based demand, primarily from lead generation and e-commerce advertisers, increased 90% year-over-year, while IAA spending rose 97%.

JOYY said South America remained the largest market for BIGO Ads, while Western Europe showed momentum with revenue up 27% sequentially.

During the question-and-answer session, Ting Li said BIGO Ads’ better-than-expected performance reflected progress in lead generation, direct-to-consumer e-commerce and IAA, along with upgrades to algorithm capabilities. She said JOYY had completed a framework upgrade to its core predictive model and was seeing improvements in monetization efficiency, advertiser retention and average advertiser spending.

Management reiterated its goal for BIGO Audience Network to reach $1 billion in revenue by 2028. Alex Liu, vice president of finance, said the business remains profitable while the company continues investing in research and development, sales, network infrastructure and computing capacity.

Shopline moves into standalone reporting Shopline revenue was $30.5 million in the first quarter, up 16.1% year-over-year. Gross margin expanded 6.8 percentage points from a year earlier to 51.5%, which Liu attributed to growth in higher-margin subscription revenue and improving margins in value-added services.

Management described Shopline as an “AI-native” omnichannel commerce infrastructure platform, designed to support merchants across store setup, transactions, fulfillment, payments, logistics, marketing and customer retention.

Revenue from cross-border merchants grew 66% year-over-year, and Xie said cross-border merchant revenue continued to grow at more than 60%. The company expects Shopline revenue growth to accelerate to above 25% year-over-year in the second quarter.

Asked by BOCI Research analyst Raphael Chen about Shopline’s profitability path, Ting Li said the business has a differentiated model based on recurring subscription fees and value-added services such as payments and marketing. She said research and development spending, the largest component of Shopline’s operating expenses, has largely stabilized, creating operating leverage as revenue and gross profit grow. Management said Shopline is on a path to reach breakeven by 2028.

New $1.5 billion shareholder return plan JOYY also announced an expanded three-year shareholder return program totaling $1.5 billion for fiscal years 2026 through 2028. The program includes up to $600 million in share repurchases and approximately $900 million in dividends.

Through May 22, the company had repurchased $87.9 million of shares and paid $69 million in dividends since the start of 2026, returning a total of $156.8 million to shareholders.

In response to a question from CICC analyst Xueqing Zhang, Liu said the new plan replaces a previous $900 million program and represents a roughly 67% increase in the company’s shareholder return commitment. He said the updated plan includes $300 million in annual dividends and an annualized buyback authorization of $200 million.

Liu said the decision reflected the growth trajectory of all three segments, JOYY’s net cash position and management’s view that the current share price “materially undervalues” the company’s long-term potential.

Second-quarter and full-year outlook For the second quarter of 2026, JOYY guided for net revenue of $562 million to $581 million, implying year-over-year growth of 10.7% to 14.4%.

By segment, Liu said management expects social entertainment to grow in the low- to mid-single-digit range, BIGO Ads to sustain mid-double-digit growth and Shopline to accelerate to more than 25% growth. For the full year, JOYY expects solid positive group revenue growth, with social entertainment delivering steady growth, BIGO Ads producing strong mid-double-digit growth and Shopline sustaining double-digit growth.

On profitability, Liu said JOYY expects group non-GAAP operating profit and EBITDA to continue the improving trend seen in 2025, with “steady teens” year-over-year growth in 2026. He noted that unrealized foreign-exchange losses weighed on first-quarter net income due to the weakening U.S. dollar against the renminbi and said similar effects are expected in the second quarter.

About JOYY NASDAQ: YYJOYY Inc NASDAQ: YY is a global technology-driven social media company specializing in video-based content creation and real-time social entertainment. The company develops and operates platforms that enable users to broadcast live video, engage with audiences and participate in interactive social communities. Its flagship global products include Bigo Live, a live-streaming application, and Likee, a short-video creation and sharing platform, which collectively support real-time interaction through virtual gifting and in-app social features.

Originally founded in Guangzhou, China in 2005 by David Xueling Li under the name YY Inc, the company pioneered real-time group communication and live streaming services in its domestic market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in JOYY Right Now?Before you consider JOYY, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JOYY wasn't on the list.

While JOYY currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
2026-06-12 19:39 1mo ago
2026-05-26 04:37 2mo ago
JOYY Inc. (JOYY) Q1 2026 Earnings Call Transcript
YY JOYY
FMP Stock News
Original source text
JOYY Inc. (JOYY) Q1 2026 Earnings Call Transcript
2026-06-12 19:39 1mo ago
2026-05-26 16:57 2mo ago
JOYY Inc.: Positive About Outlook Surprise And Generous Returns
YY JOYY
FMP Stock News
Original source text
My 'Buy' rating for JOYY Inc. remains intact, following my assessment of its financial and capital return prospects. JOYY's 1Q26 revenue rose 12.4% YoY, with its above-consensus 2Q26 guidance of $571.5 million implying an even superior 12.6% increase. JOYY has raised its targeted shareholder returns for FY26-28 from $900 million previously to $1.5 billion now.
2026-06-12 19:39 1mo ago
2026-05-27 08:25 2mo ago
JOYY: Mediocre Earnings And Blockbuster Value Plan
YY JOYY
FMP Stock News
Original source text
JOYY stays undervalued in light of a supersized program for shareholder returns. 1Q26 results largely meet expectations, with revenue rising and gross margin slightly shrinking. I maintain a buy rating with an adjusted price target of $94.5, based on discounted dividends and the company's net cash.
2026-06-12 19:39 1mo ago
2026-05-29 05:31 2mo ago
JOYY Inc: Getting Back On Track Although Pitfalls Remain
YY JOYY
FMP Stock News
Original source text
The Q1 FY2026 report came at a crucial time with the stock in need of assistance to fend off a breakdown further into bear market territory. JOYY managed to reverse a precarious situation with an acceleration in growth and increased capital returns to shareholders. JOYY has a lot going for it, but it is also not without blemishes, which includes more goodwill on the balance sheet some may be comfortable with.
2026-06-12 19:39 1mo ago
2026-04-28 06:30 3mo ago
Zimmer Biomet Announces First Quarter 2026 Financial Results
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
First quarter net sales of $2.087 billion increased 9.3% on a reported basis, 6.8% on a constant currency1 basis and 2.9% on an organic constant currency1 basis First quarter diluted earnings per share were $1.22, an increase of 34.1%; adjusted1 diluted earnings per share were $2.09, an increase of 15.5% Company updates full-year 2026 financial guidance , /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2026.  The Company reported first quarter net sales of $2.087 billion, an increase of 9.3% over the prior year period, an increase of 6.8% on a constant currency1 basis and an increase of 2.9% on an organic constant currency1 basis.  Net earnings for the first quarter were $238.1 million, or $409.4 million on an adjusted1 basis.

Diluted earnings per share were $1.22 for the first quarter, an increase of 34.1%, and adjusted1 diluted earnings per share were $2.09, an increase of 15.5%.  Zimmer Biomet generated $359.4 million in operating cash flow and $245.9 million of free cash flow in the first quarter.

"We are off to a solid start to the year — strategically, operationally and financially," said Ivan Tornos, Chairman, President and CEO of Zimmer Biomet. "Our first quarter results reflect healthy end markets, continued momentum from our recently launched products and disciplined execution across the business. Given our progress and with our go-to-market transformation proceeding as planned, we are raising our adjusted EPS guidance and free cash flow expectations for the year. We remain confident that our strategy will position Zimmer Biomet for consistent, durable growth over the longer term."

1 Reconciliations of these measures to the corresponding U.S. generally accepted accounting principles measures are included in this press release.

Recent Highlights

Completed $250 million of share repurchases during the first quarter of fiscal 2026. Named Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer to oversee the strategy, delivery and management of the company's global end-to-end technology portfolio, including AI, robotics, smart implants and data. Completed enrollment in the multi-center clinical study in India of mBôs, a first-of-its-kind, surgeon-guided, autonomous robotic total knee arthroplasty system acquired from Monogram Technologies. This marks a key development milestone and helps ensure future regulatory and commercialization pathways remain on track. First case completed using the G7®TM Acetabular System, a next-generation implant engineered to address challenging primary and revision hip replacement surgeries, following U.S. Food and Drug Administration (FDA) 510(k) clearance in February 2026. Released new data and showcased a broad portfolio of innovations at the 2026 American Academy of Orthopaedic Surgeons (AAOS) annual meeting, including the full commercial launch of ROSA® Knee with OptimiZe. Named to FORTUNE's 2026 list of America's Most Innovative Companies and to Ethisphere's list of the World's Most Ethical Companies for the second straight year. Launched Phantom® Curved TTC Nail System, a next-generation solution from Paragon 28 subsidiary to support hindfoot fusion procedures. Geographic and Product Category Sales
The following sales table provides results by geography and product category for the three-month period ended March 31, 2026, as well as the percentage change compared to the prior year period, on both a reported basis and a constant currency basis.  Percentage change is also presented on an organic constant currency basis to exclude the impact on net sales from the April 2025 acquisition of Paragon 28, Inc. ("Paragon 28").

NET SALES - THREE MONTHS ENDED MARCH 31, 2026

(in millions, unaudited)

Organic

Constant

Constant

Net

Currency

Currency

Sales

% Change

% Change

% Change

Geographic Results

United States

$

1,209.4

8.6

%

8.6

%

3.2

%

International

877.4

10.3

4.2

2.5

Total

$

2,086.7

9.3

%

6.8

%

2.9

%

Product Categories

Knees

United States

$

469.2

2.2

%

2.2

%

2.2

%

International

359.4

7.6

1.3

1.3

Total

828.6

4.5

1.8

1.8

Hips

United States

277.5

5.0

5.0

5.0

International

246.6

6.5

1.0

1.0

Total

524.1

5.7

3.2

3.2

S.E.T. *

562.2

19.5

17.4

1.6

Technology & Data, Bone Cement and Surgical

171.8

14.6

11.7

11.7

Total

$

2,086.7

9.3

%

6.8

%

2.9

%

* Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic

Amounts reported in millions are computed based on the actual amounts.  As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding.  Percentages presented are calculated from the underlying unrounded amounts.

Financial Guidance

The Company is updating its full-year 2026 financial guidance as follows:

Projected Year Ending December 31, 2026

Previous Guidance

Updated Guidance

2026 Reported Revenue Change

2.5% - 4.5%

2.5% - 4.5%

Foreign Currency Exchange Impact

+0.5 %

+0.5 %

2026 Constant Currency Revenue Change

2.0% - 4.0%

2.0% - 4.0%

2026 Organic Constant Currency Revenue Change(1)

1.0% - 3.0%

1.0% - 3.0%

Adjusted Diluted EPS(2)

$8.30 - $8.45

$8.40 - $8.55

(1)

Excludes the projected impact of the Paragon 28 acquisition through the one-year anniversary of the acquisition date, which is estimated to be approximately 100bps.

(2)

This measure is a non-GAAP financial measure for which a reconciliation to the most directly comparable GAAP financial measure is not available without unreasonable efforts.  See "Forward-Looking Non-GAAP Financial Measures" below, which identifies the information that is unavailable without unreasonable efforts and provides additional information.  It is probable that this forward-looking non-GAAP financial measure may be materially different from the corresponding GAAP financial measure.

Conference Call

The Company will conduct its first quarter 2026 investor conference call today, April 28, 2026, at 8:30 a.m. ET.  The audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com.  It will be archived for replay following the conference call. 

About the Company

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health.  We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. 

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers.  Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.x.com/zimmerbiomet.  

Website Information

We routinely post important information for investors on our website, www.zimmerbiomet.com, in the "Investor Relations" section.  We use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD.  Accordingly, investors should monitor the Investor Relations section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. 

The information contained on, or that may be accessed through, our website or any other website referenced herein is not incorporated by reference into, and is not a part of, this document.

Note on Non-GAAP Financial Measures

This press release and our commentary in our investor conference call today include non-GAAP financial measures that differ from financial measures calculated in accordance with U.S. generally accepted accounting principles ("GAAP").  These non-GAAP financial measures may not be comparable to similar measures reported by other companies and should be considered in addition to, and not as a substitute for, or superior to, other measures prepared in accordance with GAAP.

Net sales change information for the three-month period ended March 31, 2026 is presented on a GAAP (reported) basis and on a constant currency basis. Net sales change for this period is also presented on an organic constant currency basis to exclude the impact on net sales from the April 2025 acquisition of Paragon 28.  Constant currency percentage changes exclude the effects of foreign currency exchange rates.  They are calculated by translating current and prior-period sales at the same predetermined exchange rate.  The translated results are then used to determine year-over-year percentage increases or decreases.  Projected revenue change information for the year ending December 31, 2026, is also presented on an organic constant currency basis.  In addition to excluding the projected effects of foreign currency exchange rates, projected 2026 organic constant currency revenue change also excludes the projected impact on net sales from the April 2025 acquisition of Paragon 28 through the one-year anniversary of the acquisition date in April 2026.

Net earnings and diluted earnings per share for the three-month periods ended March 31, 2026 and 2025 are presented on a GAAP (reported) basis and on an adjusted basis.  These adjusted financial measures exclude the effects of certain items, which are detailed in the reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures presented later in the press release. 

Free cash flow is an additional non-GAAP measure that is presented in this press release.  Free cash flow is computed by deducting additions to instruments and other property, plant and equipment from net cash provided by operating activities.

Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in this press release.  This press release also contains supplemental reconciliations of additional non-GAAP financial measures that the Company presents in other contexts.  These additional non-GAAP financial measures are computed from the most directly comparable GAAP financial measure as indicated in the applicable reconciliation.

Management uses non-GAAP financial measures internally to evaluate the performance of the business.  Additionally, management believes these non-GAAP measures provide meaningful incremental information to investors to consider when evaluating the performance of the Company.  Management believes these measures offer the ability to make period-to-period comparisons that are not impacted by certain items that can cause dramatic changes in reported income but that do not impact the fundamentals of our operations.  The non-GAAP measures enable the evaluation of operating results and trend analysis by allowing a reader to better identify operating trends that may otherwise be masked or distorted by these types of items that are excluded from the non-GAAP measures.  In addition, constant currency revenue change, adjusted operating profit, adjusted diluted earnings per share and free cash flow are used as performance metrics in our incentive compensation programs.

Forward-Looking Non-GAAP Financial Measures

This press release and our commentary in our investor conference call today also include certain forward-looking non-GAAP financial measures for the year ending December 31, 2026.  We calculate forward-looking non-GAAP financial measures based on internal forecasts that omit certain amounts that would be included in GAAP financial measures.  For instance, we exclude the impact of restructuring and other cost reduction initiatives; acquisition, integration, divestiture and related; and certain legal and tax matters.  We have not provided quantitative reconciliations of these forward-looking non-GAAP financial measures (other than projected 2026 organic constant currency revenue change) to the most directly comparable forward-looking GAAP financial measures because the excluded items are not available on a prospective basis without unreasonable efforts.  For example, the timing of certain transactions is difficult to predict because management's plans may change.  In addition, the Company believes such reconciliations would imply a degree of precision and certainty that could be confusing to investors.  It is probable that these forward-looking non-GAAP financial measures may be materially different from the corresponding GAAP financial measures.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding financial guidance, statements regarding macro pressures, including the impact of such pressures on our business, and any statements about our forecasts, expectations, plans, intentions, commitments, strategies or prospects.  All statements other than statements of historical or current fact are, or may be deemed to be, forward-looking statements.  Such statements are based upon the current beliefs, expectations and assumptions of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements.  These risks, uncertainties and changes in circumstances include, but are not limited to: competition; pricing pressures; dependence on new product development, technological advances and innovation; changes in customer demand for our products and services caused by demographic changes, obsolescence, development of different therapies or other factors; our ability to attract, retain, develop and maintain adequate succession plans for the highly skilled employees, senior management, independent agents and distributors we need to support our business; the transformation of our sales and distribution network in the U.S. and other markets; challenges relating to the rationalization of our products; shifts in the product category or regional sales mix of our products and services; the risks and uncertainties related to our ability to successfully execute our restructuring plans; the risks and uncertainties relating to our ability to successfully execute on our product portfolio rationalization plans; control of costs and expenses; risks related to the ability to realize the anticipated benefits of our acquisitions, including the possibility that the expected benefits from such transactions will not be realized or will not be realized within the expected time period; the risk that acquired businesses will not be integrated successfully; the effects of business disruptions affecting us, our suppliers, customers or payors, either alone or in combination with other risks on our business and operations; the risks and uncertainties related to our ability to successfully integrate the operations, products, service providers, agents, employees, sales representatives and distributors of acquired companies; the effect of the potential disruption of management's attention from ongoing business operations due to integration matters related to mergers and acquisitions; the effect of mergers and acquisitions on our relationships with customers, suppliers and lenders and on our operating results and businesses generally; unplanned delays, disruptions and expenses attributable to our enterprise resource planning and other system updates; the ability to form and implement alliances; dependence on a limited number of suppliers for key raw materials and other inputs and for outsourced activities; the risk of disruptions in the supply of materials and components used in manufacturing or sterilizing our products; breaches or failures of our (or of our business partners' or other third parties') information technology systems or products, including by cyberattack, unauthorized access or theft; the outcome of government investigations; the impact of healthcare reform and cost containment measures, including efforts sponsored by government agencies, legislative bodies, the private sector and healthcare purchasing organizations, through reductions in reimbursement levels, repayment demands and otherwise; the effects of natural disasters, or of legal, regulatory or market measures to address natural disasters; the effects of our commitments, goals and disclosures relating to corporate responsibility matters; the impact of substantial indebtedness on our ability to service our debt obligations and/or refinance amounts outstanding under our debt obligations at maturity on terms favorable to us, or at all; changes in tax obligations arising from examinations by tax authorities and from changes in tax laws in jurisdictions where we do business, including as a result of the "base erosion and profit shifting" project undertaken by the Organisation for Economic Co-operation and Development and otherwise; challenges to the tax-free nature of the ZimVie Inc. spinoff transaction and the subsequent liquidation of our retained interest in ZimVie Inc.; the risk of additional tax liability due to the recategorization of our independent agents and distributors to employees; changes in tariffs relating to imports to the U.S. and other countries; the risk that material impairment of the carrying value of our intangible assets, including goodwill, could negatively affect our operating results; changes in general domestic and international economic conditions, including interest rate and currency exchange rate fluctuations; changes in general industry and market conditions, including domestic and international growth, inflation and currency exchange rates; the domestic and international business impact of political, social and economic instability, tariffs, trade restrictions and embargoes, sanctions, wars, disputes and other conflicts, including on our ability to operate in, export from or collect accounts receivable in affected countries; challenges relating to changes in and compliance with governmental laws and regulations affecting our U.S. and international businesses, including regulations of the U.S. Food and Drug Administration ("FDA") and other government regulators relating to medical products, healthcare fraud and abuse laws and data privacy and cybersecurity laws; the success of our quality and operational excellence initiatives; the ability to remediate matters identified in inspectional observations issued by the FDA and other regulators, while continuing to satisfy the demand for our products; product liability, intellectual property and commercial litigation losses; and the ability to obtain and maintain adequate intellectual property protection.  A further list and description of these risks and uncertainties and other factors can be found in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and our subsequent filings with the Securities and Exchange Commission (SEC).  Copies of these filings are available online at www.sec.gov, www.zimmerbiomet.com or on request from us. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in our filings with the SEC.  Forward-looking statements speak only as of the date they are made, and we expressly disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements since there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary note is applicable to all forward-looking statements contained in this press release.

Note: Amounts reported in millions within this press release are computed based on the actual amounts.  As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding.  Certain columns and rows within tables may not add due to the use of rounded numbers.  Percentages presented are calculated from the underlying unrounded amounts.

ZIMMER BIOMET HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

(in millions, except per share amounts, unaudited)

2026

2025

Net Sales

$

2,086.7

$

1,909.1

Cost of products sold, excluding intangible asset amortization

576.2

549.8

Intangible asset amortization

162.1

151.0

Research and development

103.4

110.6

Selling, general and administrative

849.9

758.8

Restructuring and other cost reduction initiatives

6.3

36.0

Acquisition, integration, divestiture and related

15.6

10.6

Operating expenses

1,713.5

1,616.8

Operating Profit

373.2

292.3

Other (expense) income, net

(3.0)

2.9

Interest expense, net

(68.8)

(66.2)

Earnings before income taxes

301.3

229.0

Provision for income taxes

63.0

46.5

Net Earnings

238.3

182.6

Less: Net earnings attributable to noncontrolling interest

0.2

0.6

Net Earnings of Zimmer Biomet Holdings, Inc.

$

238.1

$

182.0

Earnings Per Common Share

Basic

$

1.22

$

0.92

Diluted

$

1.22

$

0.91

Weighted Average Common Shares Outstanding

Basic

195.0

198.9

Diluted

195.8

199.7

The condensed consolidated statement of earnings for the three-months ended March 31, 2026, reported in this press release are based on an initial assessment that the Company will not record a goodwill impairment charge in the first quarter 2026.  The Company is finalizing its estimated fair value assessment of such goodwill, and therefore the determination of whether an impairment charge will be recorded, and the amount of any such charge, is not complete and subject to change.  If an impairment charge is recorded, our GAAP net earnings information related to the first quarter of 2026 in this release will differ from what is reported in this release. The final determination regarding any impairment, and the impact on results if there is an impairment, will be included in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.

ZIMMER BIOMET HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, unaudited)

March 31,

December 31,

2026

2025

Assets

Cash and cash equivalents

$

424.2

$

591.9

Receivables, net

1,728.6

1,704.4

Inventories

2,246.8

2,286.4

Other current assets

562.9

537.3

Total current assets

4,962.5

5,119.9

Property, plant and equipment, net

2,211.7

2,207.1

Goodwill

9,931.8

9,947.1

Intangible assets, net

4,547.6

4,717.3

Other assets

1,067.9

1,100.3

Total Assets

$

22,721.6

$

23,091.7

Liabilities and Stockholders' Equity

Current liabilities

$

1,688.4

$

1,996.6

Current portion of long-term debt

1,175.9

587.1

Other long-term liabilities

880.6

870.2

Long-term debt

6,295.1

6,932.0

Stockholders' equity

12,681.6

12,705.8

Total Liabilities and Stockholders' Equity

$

22,721.6

$

23,091.7

ZIMMER BIOMET HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

(in millions, unaudited)

2026

2025

Cash flows provided by (used in) operating activities

Net earnings

$

238.3

$

182.6

Depreciation and amortization

270.0

254.4

Share-based compensation

24.2

19.6

Changes in operating assets and liabilities, net of acquired assets and
liabilities

Income taxes

(7.4)

(15.6)

Receivables

14.5

(18.8)

Inventories

(20.9)

(3.0)

Accounts payable and accrued liabilities

(183.0)

(36.4)

Other assets and liabilities

23.5

(0.1)

Net cash provided by operating activities

359.4

382.8

Cash flows provided by (used in) investing activities

Additions to instruments

(77.2)

(59.7)

Additions to other property, plant and equipment

(36.3)

(44.6)

Net investment hedge settlements

(0.3)

1.0

Acquisition of intangible assets

(39.0)

(2.4)

Other investing activities

(6.2)

(0.3)

Net cash used in investing activities

(159.0)

(106.0)

Cash flows provided by (used in) financing activities

Proceeds from senior notes

-

1,748.1

Redemption of senior notes

-

(863.0)

Dividends paid to stockholders

(46.9)

(47.8)

Proceeds from employee stock compensation plans

12.3

16.7

Business combination contingent consideration payments

(69.0)

(17.4)

Debt issuance costs

-

(16.1)

Repurchase of common stock

(250.1)

(229.8)

Other financing activities

(15.6)

(15.2)

Net cash (used in) provided by financing activities

(369.2)

575.4

Effect of exchange rates on cash and cash equivalents

1.1

7.0

Change in cash and cash equivalents

(167.7)

859.1

Cash and cash equivalents, beginning of year

591.9

525.5

Cash and cash equivalents, end of period

$

424.2

$

1,384.5

ZIMMER BIOMET HOLDINGS, INC.

RECONCILIATION OF REPORTED NET SALES % CHANGE TO

CONSTANT CURRENCY AND ORGANIC CONSTANT CURRENCY % CHANGE

(unaudited)

For the Three Months Ended

March 31, 2026 vs. 2025

Organic

Foreign

Constant

Paragon

Constant

Exchange

Currency

28

Currency

% Change

Impact

% Change

Impact

% Change

Geographic Results

United States

8.6

%

-

%

8.6

%

5.4

%

3.2

%

International

10.3

6.1

4.2

1.7

2.5

Total

9.3

%

2.5

%

6.8

%

3.9

%

2.9

%

Product Categories

Knees

United States

2.2

%

-

%

2.2

%

-

%

2.2

%

International

7.6

6.3

1.3

-

1.3

Total

4.5

2.7

1.8

-

1.8

Hips

United States

5.0

-

5.0

-

5.0

International

6.5

5.5

1.0

-

1.0

Total

5.7

2.5

3.2

-

3.2

S.E.T.

19.5

2.1

17.4

15.8

1.6

Technology & Data, Bone
Cement and Surgical

14.6

2.9

11.7

-

11.7

Total

9.3

%

2.5

%

6.8

%

3.9

%

2.9

%

ZIMMER BIOMET HOLDINGS, INC.

RECONCILIATION OF REPORTED TO ADJUSTED RESULTS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

(in millions, except per share amounts, unaudited)

FOR THE THREE MONTHS ENDED MARCH 31, 2026

Cost of products
sold, excluding
intangible asset
amortization

Intangible asset
amortization

Restructuring
and other cost
reduction
initiatives

Acquisition,
integration,
divestiture
and related

Other
(expense)
income, net

Provision for
income taxes

Net Earnings
of Zimmer
Biomet
Holdings, Inc.

Diluted
earnings
per
common
share

As Reported

$

576.2

$

162.1

$

6.3

$

15.6

$

(3.0)

$

63.0

$

238.1

$

1.22

Inventory and manufacturing-related
charges(1)

(13.3)

-

-

-

-

3.6

9.7

0.05

Intangible asset amortization(2)

-

(162.1)

-

-

-

34.2

127.9

0.65

Restructuring and other cost reduction
initiatives(3)

-

-

(6.3)

-

-

1.0

5.3

0.03

Acquisition, integration, divestiture and
related(4)

-

-

-

(15.6)

-

1.4

14.2

0.07

Other charges(5)

-

-

-

-

0.8

0.2

0.6

-

Other certain tax adjustments(6)

-

-

-

-

-

(13.5)

13.5

0.07

As Adjusted

$

562.9

$

-

$

-

$

-

$

(2.2)

$

89.9

$

409.4

$

2.09

FOR THE THREE MONTHS ENDED MARCH 31, 2025

Cost of
products sold,
excluding intangible
asset
amortization

Intangible
asset
amortization

Research and
development

Restructuring
and other
cost
reduction
initiatives

Acquisition,
integration,
divestiture
and related

Interest
expense,
net

Provision
for income
taxes

Net
Earnings of
Zimmer
Biomet
Holdings,
Inc.

Diluted
earnings per
common
share

As Reported

$

549.8

$

151.0

$

110.6

$

36.0

$

10.6

$

(66.2)

$

46.5

$

182.0

$

0.91

Inventory and manufacturing-related
charges(1)

(6.2)

-

-

-

-

-

2.1

4.1

0.02

Intangible asset amortization(2)

-

(151.0)

-

-

-

-

28.2

122.8

0.61

Restructuring and other cost
reduction initiatives(3)

-

-

-

(36.0)

-

-

7.2

28.8

0.14

Acquisition, integration, divestiture
and related(4)

-

-

-

-

(10.6)

-

1.9

8.7

0.04

European Union Medical Device
Regulation(7)

-

-

(4.4)

-

-

-

0.9

3.5

0.02

Other charges(5)

-

-

-

-

-

4.8

2.7

2.1

0.01

Other certain tax adjustments(6)

-

-

-

-

-

-

(9.2)

9.2

0.05

As Adjusted

$

543.6

$

-

$

106.2

$

-

$

-

$

(61.4)

$

80.3

$

361.2

$

1.81

(1)

Inventory and manufacturing-related charges include excess and obsolete inventory charges on certain product lines we intend to discontinue by 2032, inventory step-up expense, and other inventory and manufacturing-related charges or gains.  Inventory step-up expense represents the incremental expense of inventory sold recognized at its fair value after business combination accounting is applied versus the expense that would have been recognized if sold at its cost to manufacture.  Since only the inventory that existed at the business combination date was stepped-up to fair value, we believe excluding the incremental expense provides investors useful information as to what our costs may have been if we had not been required to increase the inventory's book value to fair value.  The excess and obsolete inventory charges on product lines we intend to discontinue were $1.2 million and $2.6 million in the three-month periods ended March 31, 2026 and 2025, respectively.  Inventory step-up expense was $12.0 million in the three-month period ended March 31, 2026, compared to zero in the same prior year period. 

(2)

We exclude intangible asset amortization as well as deferred tax rate changes on our intangible assets from our non-GAAP financial measures because we internally assess our performance against our peers without this amortization.  Due to various levels of acquisitions among our peers, intangible asset amortization can vary significantly from company to company.

(3)

In December 2019, 2021 and 2023, and in February and December 2025, we initiated global restructuring programs that included a reorganization of key businesses and an overall effort to reduce costs in order to accelerate decision-making, focus the organization on priorities to drive growth and, in the case of the December 2021 program, to prepare for the spinoff of ZimVie Inc. ("ZimVie").  Restructuring and other cost reduction initiatives also include other cost reduction and optimization initiatives that have the goal of reducing costs or across the organization.  The costs include employee termination benefits; contract terminations for facilities and sales agents; and other charges, such as consulting fees, project management expenses, retention period salaries and benefits and relocation costs. 

(4)

The acquisition, integration, divestiture and related gains and expenses we have excluded from our non-GAAP financial measures resulted from various acquisitions, post-separation costs we have incurred related to ZimVie and gains related to a transition services agreement for services we provide to ZimVie and a transition manufacturing and supply agreement for products we supply to ZimVie for a limited period.  In the three-month periods ended March 31, 2026 and 2025, this line item includes $8.1 million and $1.7 million of expenses, respectively, related to changes in the estimated fair values of contingent consideration due to updated forecasts of net sales from certain acquisitions. 

(5)

We have incurred other various expenses from specific events or projects that we consider highly variable or that have a significant impact to our operating results that we have excluded from our non-GAAP measures.  These include gains and losses from changes in fair value on our equity investments, impairment of instruments related to certain product lines we intend to discontinue, among other various costs.  In addition, in February 2025 we issued senior notes in order to have the necessary cash-on-hand to acquire Paragon 28 once regulatory approval was received.  We have excluded from our non-GAAP financial measures the interest on this debt related to the principal amount of the estimated purchase price and acquisition-related costs up through the acquisition date.  Interest expense subsequent to the acquisition date has not been excluded. 

(6)

Other certain tax adjustments are primarily related to significant and discrete tax adjustments.  The primary adjustments include benefits of $12.1 million and $8.5 million in three-month periods ended March 31, 2026 and 2025, respectively, related to Swiss tax reform.

(7)

The European Union Medical Device Regulation imposes significant additional premarket and postmarket requirements.  The new regulations provided a transition period until May 2021 for previously-approved medical devices to meet the additional requirements.  For certain devices, this transition period was extended until May 2024.  A conditional extension of the transition period has been implemented until December 2027 and 2028 depending on the legacy medical device's risk class.  We are excluding from our non-GAAP financial measures the incremental costs incurred to establish initial compliance with the regulations related to our previously-approved medical devices.  The incremental costs primarily relate to temporary personnel and third-party professionals necessary to supplement our internal resources.  Starting January 1, 2026, we do not expect to incur any significant incremental costs related to these new regulations.

ZIMMER BIOMET HOLDINGS, INC.

RECONCILIATION OF NET CASH PROVIDED BY OPERATING

ACTIVITIES TO FREE CASH FLOW

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

(in millions, unaudited)

Three Months Ended March 31,

2026

2025

Net cash provided by operating activities

$

359.4

$

382.8

Additions to instruments

(77.2)

(59.7)

Additions to other property, plant and equipment

(36.3)

(44.6)

Free cash flow

$

245.9

$

278.5

ZIMMER BIOMET HOLDINGS, INC.

RECONCILIATION OF GROSS PROFIT & MARGIN

TO ADJUSTED GROSS PROFIT & MARGIN

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

(in millions, unaudited)

Three Months Ended March 31,

2026

2025

Net Sales

$

2,086.7

$

1,909.1

Cost of products sold, excluding intangible asset amortization

576.2

549.8

Intangible asset amortization

162.1

151.0

Gross Profit

$

1,348.4

$

1,208.3

Inventory and manufacturing-related charges

13.3

6.2

Intangible asset amortization

162.1

151.0

Adjusted gross profit

$

1,523.8

$

1,365.5

Gross margin

64.6

%

63.3

%

Inventory and manufacturing-related charges

0.6

0.3

Intangible asset amortization

7.8

7.9

Adjusted gross margin

73.0

%

71.5

%

ZIMMER BIOMET HOLDINGS, INC.

RECONCILIATION OF OPERATING PROFIT & MARGIN TO ADJUSTED OPERATING PROFIT & MARGIN

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

(in millions, unaudited)

Three Months Ended
March 31,

2026

2025

Operating profit

$

373.2

$

292.3

Inventory and manufacturing-related charges

13.3

6.2

Intangible asset amortization

162.1

151.0

Restructuring and other cost reduction initiatives

6.3

36.0

Acquisition, integration, divestiture and related

15.6

10.6

European Union Medical Device Regulation

-

4.4

Adjusted operating profit

$

570.5

$

500.5

Operating profit margin

17.9

%

15.3

%

Inventory and manufacturing-related charges

0.6

0.3

Intangible asset amortization

7.8

7.9

Restructuring and other cost reduction initiatives

0.3

1.9

Acquisition, integration, divestiture and related

0.7

0.6

European Union Medical Device Regulation

-

0.2

Adjusted operating profit margin

27.3

%

26.2

%

ZIMMER BIOMET HOLDINGS, INC.

RECONCILIATION OF EFFECTIVE TAX RATE TO ADJUSTED EFFECTIVE TAX RATE

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

(unaudited)

Three Months Ended March 31,

2026

2025

Effective tax rate

20.9

%

20.3

%

Tax effect of adjustments made to earnings before taxes(1)

1.6

1.9

Other certain tax adjustments (2)

(4.5)

(4.0)

Adjusted effective tax rate

18.0

%

18.2

%

(1) Includes inventory and manufacturing-related charges; intangible asset amortization; restructuring and other cost reduction initiatives; acquisition, integration, divestiture and related; litigation; European Union Medical Device Regulation; and other charges

(2) Other certain tax adjustments are primarily related to significant and discrete tax adjustments. The primary adjustments include benefits of $12.1 million and $8.5 million in the three-month periods ended March 31, 2026 and 2025, respectively, related to Swiss tax reform.

ZIMMER BIOMET HOLDINGS, INC.

RECONCILIATION OF DEBT TO NET DEBT

AS OF MARCH 31, 2026 and DECEMBER 31, 2025

(in millions, unaudited)

March 31, 2026

December 31, 2025

Debt, both current and long-term

$

7,471.0

$

7,519.1

Cash and cash equivalents

(424.2)

(591.9)

Net debt

$

7,046.8

$

6,927.2

Media

Investors

Troy Kirkpatrick

David DeMartino

614-284-1926

646-531-6115

[email protected] 

[email protected] 

Kirsten Fallon

Zach Weiner

781-779-5561

908-591-6955

[email protected] 

[email protected] 

SOURCE Zimmer Biomet Holdings, Inc.
2026-06-12 19:39 1mo ago
2026-04-28 08:29 3mo ago
Medical device maker Zimmer Biomet raises annual profit forecast, announces CFO departure
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
The logo of medical implants maker Zimmer Biomet is seen at a plant in Winterthur, Switzerland, November 16, 2018. REUTERS/Moritz Hager/File Photo Purchase Licensing Rights, opens new tab

SummaryCompanies2026 profit forecast raised after Q1 earnings beat, aided by tariffs and lower costsU.S. salesforce overhaul caused disruption, including loss of two large customer accountsCFO Suketu Upadhyay ​to depart, Paul Stellato named interim CFO during searchApril 28 (Reuters) - Medical device maker Zimmer Biomet (ZBH.N), opens new tab struck a cautious tone on Tuesday, as disruption from a U.S. sales force overhaul and an unchanged revenue outlook overshadowed a profit ​forecast raise, sending its shares down about 7% in morning trading.

The company raised ​its 2026 adjusted profit forecast after beating Wall Street estimates for ⁠the first quarter, aided by the invalidation of U.S. tariffs and lower restructuring costs ​compared with the previous year.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

However, it left its full‑year organic, constant‑currency revenue growth forecast unchanged ​at 1% to 3%, saying it was "early in the year" and that 2026 remains a period of transition.

Zimmer Biomet is in the middle of a multi‑year shift to a more dedicated and specialized U.S. ​sales model, a transition CEO Ivan Tornos said caused modest disruption in the quarter, ​including the loss of two large customer accounts.

"As strong as the first quarter was, this is ‌a year ⁠of transition," Tornos said, pointing to continued investment in the U.S. commercial channel, changes to distributor structures in some international markets and execution risk tied to a heavy innovation pipeline.

Tornos noted improved productivity in territories that have already transitioned but acknowledged U.S. knee ​business growth fell short ​of expectations and ⁠needs to be better.

Zimmer Biomet also announced that Chief Financial Officer Suketu Upadhyay will leave the company, with internal executive Paul ​Stellato appointed interim CFO while a search is conducted.

The company forecast ​2026 adjusted ⁠earnings of $8.40 to $8.55 per share, up from its prior range of $8.30 to $8.45.

CFO Upadhyay said they benefited from the removal of U.S. tariffs, which added about 20 cents per share to ⁠earnings, ​with about half assumed for the second half of ​the year.

First‑quarter adjusted earnings were $2.09 per share, topping analysts’ estimates of $1.86, while revenue rose 2.9% on an organic ​basis to $2.09 billion, also above expectations.

Reporting by Sahil Pandey in Bengaluru; Editing by Vijay Kishore

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-06-12 19:39 1mo ago
2026-04-28 08:41 3mo ago
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
Zimmer Biomet (ZBH - Free Report) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $1.81 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +12.57%. A quarter ago, it was expected that this orthopedic device maker would post earnings of $2.38 per share when it actually produced earnings of $2.42, delivering a surprise of +1.68%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Zimmer, which belongs to the Zacks Medical - Products industry, posted revenues of $2.09 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 1.84%. This compares to year-ago revenues of $1.91 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Zimmer shares have added about 3% since the beginning of the year versus the S&P 500's gain of 4.8%.

What's Next for Zimmer?While Zimmer has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Zimmer was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.06 on $2.15 billion in revenues for the coming quarter and $8.37 on $8.52 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 27% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Exagen Inc. (XGN - Free Report) , another stock in the same industry, has yet to report results for the quarter ended March 2026. The results are expected to be released on May 11.

This company is expected to post quarterly loss of $0.24 per share in its upcoming report, which represents a year-over-year change of -20%. The consensus EPS estimate for the quarter has been revised 21.3% lower over the last 30 days to the current level.

Exagen Inc.'s revenues are expected to be $17.13 million, up 10.5% from the year-ago quarter.
2026-06-12 19:39 1mo ago
2026-04-28 10:27 3mo ago
ZBH Q1 Earnings & Revenues Top Estimates, Stock Dips in Pre-Market
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
Key Takeaways ZBH beat Q1 estimates with EPS of $2.09 and revenues of $2.09B, both above the consensus marks. ZBH saw growth across all segments, led by S.E.T., up 17.4% and strong U.S. and international sales. ZBH expanded margins and raised 2026 EPS guidance to $8.40-$8.55, signaling improved outlook. Zimmer Biomet Holdings, Inc. (ZBH - Free Report) posted first-quarter 2026 adjusted earnings per share (EPS) of $2.09, which beat the Zacks Consensus Estimate by 12.6%. The adjusted figure rose 15.5% year over year.

The quarter’s adjustments included certain amortization, restructuring and other cost reduction initiatives, inventory and manufacturing-related charges and European Union Medical Device Regulation-related charges, among others.

GAAP EPS was $1.22 compared with 91 cents in the year-ago period. 

ZBH's RevenuesNet sales of $2.09 billion increased 9.3% (up 6.8% on a constant currency basis) year over year. The figure also surpassed the Zacks Consensus Estimate by 1.8%.

Following the earnings announcement, ZBH stock plunged 1.8% in the premarket trading today. 

ZBH's Revenues by GeographySales generated in the United States totaled $1.21 billion (up 8.6% year over year) for the quarter, while International sales grossed $877.4 million (up 10.3% year over year on a reported basis and 4.2% at CER).

Segmental Analysis of ZBH's RevenuesThe company currently reports under four product categories — Knees, Hips, S.E.T. (Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic) and Technology & Data, Bone Cement and Surgical.

Sales in the Knees unit improved 1.8% year over year at CER to $828.6 million. 

Hips’ sales grew 3.2% year over year at CER to $524.1 million. 

Revenues in the S.E.T. unit rose 17.4% year over year at CER to $562.2 million. 

Technology & Data, Bone Cement and Surgical revenues rose 11.7% to $171.8 million at CER in the first quarter. 

ZBH's Margin PerformanceAdjusted gross margin, after excluding the impact of intangible asset amortization, was 72.4%, reflecting an expansion of 119 basis points (bps) year over year. Gross margin expanded despite a 4.8% rise in the cost of products sold.

Selling, general and administrative expenses rose 12% to $849.9 million. Research and development expenses declined 6.5% to $103.4 million. Adjusted operating margin expanded 104 bps to 26.7%.

Zimmer Biomet Holdings, Inc. Price, Consensus and EPS SurpriseZBH's Cash PositionZimmer Biomet exited the first quarter of 2026 with cash and cash equivalents of $424.2 million compared with $591.9 million at the end of the fourth quarter of 2025.

Cumulative net cash provided by operating activities at the end of the first quarter was $359.4 million compared with $382.8 million in the year-ago period.

ZBH’s 2026 OutlookZimmer Biomet has updated its EPS guidance for 2026.

Revenue growth is expected to be in the band of 2.5-4.5%. The Zacks Consensus Estimate for revenues is pegged at $8.52 billion, implying 3.6% year-over-year growth. 

Adjusted EPS guidance for the full year is now expected to be in the range of $8.40-$8.55 (previously $8.30-$8.45). The Zacks Consensus Estimate for 2026 adjusted EPS is pegged at $8.37.

Our Take on ZBHZimmer Biomet exited the first quarter with better-than-expected results, wherein both earnings and revenues beat estimates. All the business segments reported growth in the quarter.

Notable developments that fueled growth include the launch of the Phantom Curved TTC Nail System, a next-generation solution to support hindfoot fusion procedures and completed first case using the G7 TM Acetabular System, a next-generation implant engineered to address challenging primary and revision hip replacement surgeries, following FDA 510(k) clearance in February 2026.

Additionally, the expansion of both margins looks encouraging. 

ZBH's Zacks Rank and Key PicksZimmer Biomet currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , Intuitive Surgical (ISRG - Free Report) and Phibro Animal Health (PAHC - Free Report) .

Globus Medical, currently sporting a Zacks Rank #1 (Strong Buy), reported a fourth-quarter 2025 adjusted EPS of $1.28, which surpassed the Zacks Consensus Estimate by 20.8%. Revenues of $826.4 million beat the Zacks Consensus Estimate by 4.9%. You can see the complete list of today’s Zacks #1 Rank stocks here. 

GMED has an earnings yield of 4.7% compared with the industry’s negative yield of 1.4%. The company’s earnings beat estimates in three of the trailing four quarters and missed on one occasion, the average surprise being 18.79%.

Intuitive Surgical, carrying a Zacks Rank #2 (Buy) at present, posted a first-quarter 2026 adjusted EPS of $2.50, exceeding the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion topped the Zacks Consensus Estimate by 6.2%.

ISRG has an earnings yield of 2.1% compared with the industry’s negative yield of 0.9%. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 16.82%.

Phibro Animal Health, carrying a Zacks Rank #2 at present, posted a second-quarter fiscal 2026 adjusted EPS of 87 cents, exceeding the Zacks Consensus Estimate by 27.01%. Revenues of $373.9 million outperformed the Zacks Consensus Estimate by 4.72%.

PAHC has an estimated long-term earnings growth rate of 21.5% compared with the industry’s 12.1% growth. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 20.15%.
2026-06-12 19:39 1mo ago
2026-04-28 10:32 3mo ago
Zimmer (ZBH) Reports Q1 Earnings: What Key Metrics Have to Say
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
Zimmer Biomet (ZBH - Free Report) reported $2.09 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 9.3%. EPS of $2.09 for the same period compares to $1.81 a year ago.

The reported revenue represents a surprise of +1.84% over the Zacks Consensus Estimate of $2.05 billion. With the consensus EPS estimate being $1.86, the EPS surprise was +12.57%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Zimmer performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net Sales- Knees- International: $359.4 million versus $360.34 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +7.6% change.Net Sales- Hips- International: $246.6 million versus $248.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +6.5% change.Net Sales- International: $877.4 million versus the two-analyst average estimate of $868.9 million. The reported number represents a year-over-year change of +10.3%.Net Sales- Hips- United States: $277.5 million versus $270.26 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5% change.Net Sales- United States: $1.21 billion compared to the $1.2 billion average estimate based on two analysts. The reported number represents a change of +8.6% year over year.Net Sales- Knees- United States: $469.2 million compared to the $470.49 million average estimate based on two analysts. The reported number represents a change of +2.2% year over year.Net Sales- Knees: $828.6 million compared to the $837.59 million average estimate based on five analysts. The reported number represents a change of +4.5% year over year.Net Sales- Technology & Data, Bone Cement and Surgical: $171.8 million compared to the $156.06 million average estimate based on five analysts.Net Sales- S.E.T: $562.2 million compared to the $553.36 million average estimate based on five analysts. The reported number represents a change of +19.5% year over year.Net Sales- Hips: $524.1 million versus $518.97 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +5.7% change.View all Key Company Metrics for Zimmer here>>>

Shares of Zimmer have returned +4.5% over the past month versus the Zacks S&P 500 composite's +12.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
2026-06-12 19:39 1mo ago
2026-04-28 14:11 3mo ago
Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript
2026-06-12 19:39 1mo ago
2026-04-28 14:55 3mo ago
Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
Zimmer Biomet Q1 Earnings Beat Driven By Tariff Benefit And Solid DemandThe company said the first quarter saw a 20-cent benefit from tariff-related items relative to its expectations.

The orthopedic implant maker reported sales of $2.087 billion, up 9.3% on a reported basis, up 6.8% on a constant currency basis, and 2.9% on an organic constant currency basis, beating the consensus of $2.07 billion.

Knee product sales increased 4.5% to $828.6 million (+1.8% organically), and hip product sales increased 5.7% (+3.2%) to $524.1 million.

Sports Medicine products generated sales of $562.2 million, up 19.5% (+1.6%).

Technology & Data, Bone Cement, and Surgical sales jumped 14.6% (+11.7%) to $171.8 million.

“We are off to a solid start to the year — strategically, operationally, and financially,” said Ivan Tornos, Chairman, President, and CEO of Zimmer Biomet. 

“Our first quarter results reflect healthy end markets, continued momentum from our recently launched products, and disciplined execution across the business,” Tornos said.

CFO Exit Triggers Interim Leadership AppointmentOn Tuesday, Zimmer Biomet said Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations, and Supply Chain, will depart the company effective immediately.

The company has named Paul Stellato, currently Controller and Chief Accounting Officer, as interim Chief Financial Officer, while the company conducts an internal and external search to identify a permanent successor.

Raised Earnings Guidance“Given our progress and with our go-to-market transformation proceeding as planned, we are raising our adjusted EPS guidance and free cash flow expectations for the year. We remain confident that our strategy will position Zimmer Biomet for consistent, durable growth over the longer term,” Tornos further added.

Zimmer Biomet raised fiscal adjusted earnings guidance from $8.30-$8.45 per share to $8.40-$8.55 per share, compared to the consensus of $8.40.

The company reaffirms 2026 sales guidance of $8.44 billion-$8.60 billion versus the consensus of $8.56 billion.

In an investor call on Tuesday, the company said it completed enrollment in a 102-patient clinical study for a fully autonomous AI-driven orthopedic robotic system.

The company expects U.S. approval and the launch of the semiautonomous version in early 2027, followed by the fully autonomous version in late 2027 or early 2028.

In anticipation of the mBos launch, the company is increasing the number of robotic clinical sales representatives, targeting to hire over 200 by the end of 2027.

ZBH Price Action: Zimmer Biomet Holdings shares were down 10.81% at $82.58 at the time of publication on Tuesday. The stock is trading at a new 52-week low, according to Benzinga Pro data.

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.
2026-06-12 19:39 1mo ago
2026-04-29 11:10 3mo ago
These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported upbeat earnings for the first quarter on Tuesday.

The company posted first-quarter adjusted earnings of $2.09 per share, up 15.5% year over year, beating the Street estimates of $1.86.

The orthopedic implant maker reported sales of $2.087 billion, up 9.3% on a reported basis, up 6.8% on a constant currency basis, and 2.9% on an organic constant currency basis, beating the consensus of $2.07 billion.

"We are off to a solid start to the year — strategically, operationally, and financially," said Ivan Tornos, Chairman, President, and CEO of Zimmer Biomet.

Zimmer Biomet raised fiscal adjusted earnings guidance from $8.30-$8.45 per share to $8.40-$8.55 per share, compared to the consensus of $8.40.

The company reaffirms 2026 sales guidance of $8.44 billion-$8.60 billion versus the consensus of $8.56 billion.

Zimmer Biomet shares fell 2.6% to trade at $80.65 on Wednesday.

These analysts made changes to their price targets on Zimmer Biomet following earnings announcement.

Considering buying ZBH stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.
2026-06-12 19:39 1mo ago
2026-04-29 15:50 3mo ago
Cwm LLC Reduces Stock Position in Zimmer Biomet Holdings, Inc. $ZBH
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 29th, 2026

Cwm LLC decreased its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 60.8% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 9,377 shares of the medical equipment provider’s stock after selling 14,532 shares during the period. Cwm LLC’s holdings in Zimmer Biomet were worth $843,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Key Financial Inc lifted its stake in shares of Zimmer Biomet by 164.6% during the third quarter. Key Financial Inc now owns 262 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 163 shares during the period. Cullen Frost Bankers Inc. lifted its stake in shares of Zimmer Biomet by 66.7% during the third quarter. Cullen Frost Bankers Inc. now owns 290 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 116 shares during the period. Root Financial Partners LLC purchased a new position in shares of Zimmer Biomet during the third quarter valued at approximately $31,000. Flagship Harbor Advisors LLC purchased a new position in shares of Zimmer Biomet during the fourth quarter valued at approximately $32,000. Finally, Mather Group LLC. purchased a new position in shares of Zimmer Biomet during the third quarter valued at approximately $36,000. Hedge funds and other institutional investors own 88.89% of the company’s stock.

Analyst Ratings Changes A number of analysts have issued reports on ZBH shares. Wall Street Zen lowered Zimmer Biomet from a “buy” rating to a “hold” rating in a research note on Sunday, April 19th. UBS Group reissued a “sell” rating and issued a $89.00 price target on shares of Zimmer Biomet in a research note on Wednesday, February 11th. Citigroup reissued a “buy” rating on shares of Zimmer Biomet in a research note on Wednesday, February 11th. BTIG Research reissued a “neutral” rating on shares of Zimmer Biomet in a research note on Monday, March 23rd. Finally, Wells Fargo & Company raised their price target on Zimmer Biomet from $93.00 to $98.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 11th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $105.95.

Check Out Our Latest Research Report on ZBH

Insider Buying and Selling at Zimmer Biomet In other news, SVP Lori Winkler sold 2,650 shares of Zimmer Biomet stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $94.66, for a total value of $250,849.00. Following the transaction, the senior vice president directly owned 10,224 shares of the company’s stock, valued at $967,803.84. The trade was a 20.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.28% of the stock is owned by corporate insiders.

Zimmer Biomet Stock Performance NYSE ZBH opened at $82.95 on Wednesday. The firm has a market capitalization of $16.06 billion, a P/E ratio of 23.43, a P/E/G ratio of 1.89 and a beta of 0.61. Zimmer Biomet Holdings, Inc. has a 1-year low of $81.35 and a 1-year high of $108.29. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.98 and a quick ratio of 1.10. The business’s 50-day simple moving average is $93.23 and its 200-day simple moving average is $92.89.

Zimmer Biomet (NYSE:ZBH – Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The medical equipment provider reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.23. The business had revenue of $2.09 billion for the quarter, compared to analyst estimates of $2.06 billion. Zimmer Biomet had a return on equity of 12.93% and a net margin of 8.56%.The company’s revenue was up 9.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.81 EPS. Zimmer Biomet has set its FY 2026 guidance at 8.400-8.550 EPS. Equities analysts predict that Zimmer Biomet Holdings, Inc. will post 8.39 EPS for the current year.

Zimmer Biomet Announces Dividend The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be paid a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, March 31st. Zimmer Biomet’s payout ratio is currently 27.12%.

Trending Headlines about Zimmer Biomet Here are the key news stories impacting Zimmer Biomet this week:

Positive Sentiment: Q1 results beat expectations — adjusted EPS $2.09 vs. $1.86 estimate and revenue $2.09B, with reported sales up ~9.3% year-over-year and margin expansion, showing underlying business strength. Zimmer Biomet Announces First Quarter 2026 Financial Results Positive Sentiment: Company raised FY-2026 adjusted EPS guidance to $8.40–$8.55 (slightly above consensus) and reiterated revenue targets, supporting forward earnings outlook. Medical device maker Zimmer Biomet raises annual profit forecast, announces CFO departure Neutral Sentiment: Analyst write-ups highlight strong segment growth, solid organic sales and improved key metrics, but note mixed pre-market reaction (shares dipped despite the beat), indicating some investor profit-taking or concern about near-term execution. ZBH Q1 Earnings & Revenues Top Estimates, Stock Dips in Pre-Market Negative Sentiment: Chief Financial Officer Suketu Upadhyay departed effective April 28; an interim CFO was named. Management turnover in the finance role is creating uncertainty and likely weighing on the stock. Zimmer Biomet Announces Chief Financial Officer Transition Negative Sentiment: Reports of a CEO exit were published alongside the earnings release; headlines about executive departures and the company’s underperformance versus peers amplified investor concern and contributed to the selloff. Zimmer Biomet falls after CEO exit, unchanged growth outlook About Zimmer Biomet (Free Report)

Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.

See Also Five stocks we like better than Zimmer Biomet

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEComerica Bank Sells 5,873 Shares of Cintas Corporation $CTAS

NEXT HEADLINE »Comerica Bank Cuts Position in Hilton Worldwide Holdings Inc. $HLT
2026-06-12 19:39 1mo ago
2026-05-01 10:40 2mo ago
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.93% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Zimmer Biomet (ZBH - Free Report) Headquartered in Warsaw, IN, Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. With operations in over 25 countries, Zimmer markets products in more than 100 countries.

ZBH is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 9.77; value investors should take notice.

Nine analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.04 to $8.44 per share. ZBH boasts an average earnings surprise of +4.9%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, ZBH should be on investors' short list.
2026-06-12 19:39 1mo ago
2026-05-04 10:46 2mo ago
Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Term
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

#1 (Strong Buy) stocks have produced an unmatched +23.93% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Zimmer Biomet (ZBH - Free Report) Headquartered in Warsaw, IN, Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. With operations in over 25 countries, Zimmer markets products in more than 100 countries.

ZBH is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. ZBH has a Growth Style Score of B, forecasting year-over-year earnings growth of 2.9% for the current fiscal year.

Nine analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.04 to $8.44 per share. ZBH also boasts an average earnings surprise of +4.9%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, ZBH should be on investors' short list.
2026-06-12 19:39 1mo ago
2026-05-06 07:30 2mo ago
Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
, /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Bank of America Securities Health Care Conference on Wednesday, May 13, 2026, with a fireside chat at 8:40 a.m. PT (11:40 a.m. ET).

A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the fireside chat.

About Zimmer Biomet 
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.

Contacts:

Media

Investors

Troy Kirkpatrick

David DeMartino

614-284-1926

646-531-6115

[email protected]

[email protected]

Kirsten Fallon

Zach Weiner

781-779-5561

908-591-6955

[email protected]

[email protected]

SOURCE Zimmer Biomet Holdings, Inc.
2026-06-12 19:39 1mo ago
2026-05-12 06:30 2mo ago
Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End
ZBH Zimmer Biomet Holdings
FMP Stock News
Original source text
, /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.

All repurchases are expected to be made under the company's existing $1.5 billion share repurchase authorization, which was approved by the Zimmer Biomet Board of Directors and announced in February 2026. The company has not made any changes to the size, duration or terms of that authorization.

The company may repurchase shares in the open market and/or enter into structured repurchase agreements with third parties. The timing and actual amount of share repurchases will depend on a variety of considerations, including market conditions, the company's stock price, capital availability and alternative uses of capital.

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding financial guidance, statements regarding macro pressures, including the impact of such pressures on our business, and any statements about our forecasts, expectations, plans, intentions, commitments, strategies or prospects. All statements other than statements of historical or current fact are, or may be deemed to be, forward-looking statements Such statements are based upon the current beliefs, expectations and assumptions of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. These risks, uncertainties and changes in circumstances include, but are not limited to: competition; pricing pressures; dependence on new product development, technological advances and innovation; changes in customer demand for our products and services caused by demographic changes, obsolescence, development of different therapies or other factors; our ability to attract, retain, develop and maintain adequate succession plans for the highly skilled employees, senior management, independent agents and distributors we need to support our business; the transformation of our sales and distribution network in the U.S. and other markets; challenges relating to the rationalization of our products; shifts in the product category or regional sales mix of our products and services; the risks and uncertainties related to our ability to successfully execute our restructuring plans; the risks and uncertainties relating to our ability to successfully execute on our product portfolio rationalization plans; control of costs and expenses; risks related to the ability to realize the anticipated benefits of our acquisitions, including the possibility that the expected benefits from such transactions will not be realized or will not be realized within the expected time period; the risk that acquired businesses will not be integrated successfully; the effects of business disruptions affecting us, our suppliers, customers or payors, either alone or in combination with other risks on our business and operations; the risks and uncertainties related to our ability to successfully integrate the operations, products, service providers, agents, employees, sales representatives and distributors of acquired companies; the effect of the potential disruption of management's attention from ongoing business operations due to integration matters related to mergers and acquisitions; the effect of mergers and acquisitions on our relationships with customers, suppliers and lenders and on our operating results and businesses generally; unplanned delays, disruptions and expenses attributable to our enterprise resource planning and other system updates; the ability to form and implement alliances; dependence on a limited number of suppliers for key raw materials and other inputs and for outsourced activities; the risk of disruptions in the supply of materials and components used in manufacturing or sterilizing our products; breaches or failures of our (or of our business partners' or other third parties') information technology systems or products, including by cyberattack, unauthorized access or theft; the outcome of government investigations; the impact of healthcare reform and cost containment measures, including efforts sponsored by government agencies, legislative bodies, the private sector and healthcare purchasing organizations, through reductions in reimbursement levels, repayment demands and otherwise; the effects of natural disasters, or of legal, regulatory or market measures to address natural disasters; the effects of our commitments, goals and disclosures relating to corporate responsibility matters; the impact of substantial indebtedness on our ability to service our debt obligations and/or refinance amounts outstanding under our debt obligations at maturity on terms favorable to us, or at all; changes in tax obligations arising from examinations by tax authorities and from changes in tax laws in jurisdictions where we do business, including as a result of the "base erosion and profit shifting" project undertaken by the Organisation for Economic Co-operation and Development and otherwise; challenges to the tax-free nature of the ZimVie Inc. spinoff transaction and the subsequent liquidation of our retained interest in ZimVie Inc.; the risk of additional tax liability due to the recategorization of our independent agents and distributors to employees; changes in tariffs relating to imports to the U.S. and other countries; the risk that material impairment of the carrying value of our intangible assets, including goodwill, could negatively affect our operating results; changes in general domestic and international economic conditions, including interest rate and currency exchange rate fluctuations; changes in general industry and market conditions, including domestic and international growth, inflation and currency exchange rates; the domestic and international business impact of political, social and economic instability, tariffs, trade restrictions and embargoes, sanctions, wars, disputes and other conflicts, including on our ability to operate in, export from or collect accounts receivable in affected countries; challenges relating to changes in and compliance with governmental laws and regulations affecting our U.S. and international businesses, including regulations of the U.S. Food and Drug Administration ("FDA") and other government regulators relating to medical products, healthcare fraud and abuse laws and data privacy and cybersecurity laws; the success of our quality and operational excellence initiatives; the ability to remediate matters identified in inspectional observations issued by the FDA and other regulators, while continuing to satisfy the demand for our products; product liability, intellectual property and commercial litigation losses; and the ability to obtain and maintain adequate intellectual property protection. A further list and description of these risks and uncertainties and other factors can be found in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and our subsequent filings with the Securities and Exchange Commission (SEC). Copies of these filings are available online at www.sec.gov, www.zimmerbiomet.com or on request from us. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in our filings with the SEC. Forward-looking statements speak only as of the date they are made, and we expressly disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.

SOURCE Zimmer Biomet Holdings, Inc.